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ABSTRACT 
 
 
SHATAVIA SHARDAY MORRISON.  Vibrio vulnificus virulence and survival 
mechanisms revealed through comparative microbial genomic analysis. 
(Under the direction of DR.CYNTHIA J. GIBAS) 
 
 A sound genome assembly and robust annotations are essential to the 
differential analysis of bacterial genomes. Using a case study data set of newly 
sequenced Vibrio vulnificus genomes, both the biology of these bacteria, and the 
bioinformatics processes that support identification of the similarities and differences 
found within the different isolates of V. vulnificus, were examined. The two main 
themes of this research are 1) identification of the virulence and survival 
mechanisms of clinical and environmental biotypes of Vibrio vulnificus and 2) 
quantification of the impact of different analysis choices on the overall biological 
conclusions of the study. Whole genome sequencing, in conjunction with 
comparative genomics, are current techniques used to capture the genetic and 
functional repertoire of organisms. It is important to consider and track analytic 
provenance in bacterial genomics because the impact of making alternate workflow 
choices can involve changing the biological interpretation of hundreds of genes, even 
in relatively simple bacterial genomes.   Chapter 1 describes the bioinformatics 
analyses used to determine the draft genome sequences of three environmental 
genotype Vibrio vulnificus reference genomes and to identify genotype-specific 
genomic regions.  Chapter 1 also highlights the functional systems including the 
virulence and survival genes that differentiate between clinical and environmental 
Vibrio vulnificus genotypes.  Chapter 2 explores the direct impact of the parameter 
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and methods selected during the assembly and annotation stage of a genome project.  
Despite decades of advances in ab initio gene prediction, method and parameter 
choices still strongly influence the identification of genes, and therefore the 
biologically significant results in a comparative genomics analysis.  Using a 
benchmarking approach based on simulation studies with a related genome, it is 
possible to identify an optimal assembly-to-annotation pipeline for the collection of 
V. vulnificus strains. A software framework for comparing the outcomes of different 
assembly-to-annotation workflows was constructed in the Taverna workflow 
management system and used to carry out the bioinformatics experiments described 
in Chapter 3. Chapter 3 expands on the analysis performed in Chapter 1 by 
performing an extensive comparative genomics analysis of newly sequenced Vibrio 
vulnificus genomes, each ones represents the different biological classifications 
found within this species. The analysis of these genomes reveals genes that are 
specific to each of the biotypes.  Comparative analysis of representative strains from 
each of the established Vibrio vulnificus biotypes is used to identify differentiating 
genes, which may relate to the apparent host-specificity of the different biotypes. 
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CHAPTER 1: PYROSEQUENCING-BASED COMPARATIVE  
GENOME ANALYSIS OF VIBRIO VULNIFICUS ENVIRONMENTAL 
ISOLATES [2] 
 
 
1.1 Introduction 
The study of microbiology presents many opportunities and challenges around 
genome sequencing.  Bacterial genome sequences evolve rapidly, and the gene 
content even closely related bacterial strains can change significantly due to 
processes such as horizontal gene transfer.  Sequencing and comparative analysis 
of bacterial genomes make it possible to identify the genes and associated 
functional capabilities that make bacteria effective as pathogens, the role in which 
they are most of concern to human health.  Using comparative genomics analysis 
techniques on collections of bacterial genome sequences can begin to elucidate the 
differences in function and gene content among these bacterial species.  
Sequencing bacterial genomes is the starting point for studies of pathogenicity, 
niche specialization, and evolutionary relationships among species.  Given the 
large amount of sequencing data that can be produced using technologies, it is not 
uncommon to perform comparative analyses of dozens of bacterial strains 
simultaneously, where even 10 years ago comparison of even two strains would 
have been considered a wealth of information.  In order to compare the multiple 
bacterial genomes that are now common, it is necessary to design and implement a 
bioinformatics infrastructure to store and track the artifacts of the analysis process.  
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While genome browsers might support alignment of two bacterial genomes, 
modern projects require a database infrastructure that supports aggregation of 
genomes into relevant classes (for example, strains that have been found in human 
infections vs. those that have only been observed in marine environments) and 
comparison of functional content across classes. 
 Described in this chapter is a large-scale approach in which multiple genomes 
are compared in order to discover the similarities and differences between the 
genomes and to stud the biology of individual strains.  There are several types of 
analyses that can be performed with comparative genomics [1] such as the 
identifying differentiating genes and genomic rearrangements.  In this work, the 
primary analysis consists of identification and comparison of protein coding 
sequence content, including gene content, protein content, orthologs, and paralogs.  
This analysis is the basis for identification of commonalities and differences between 
various biological classifications of Vibrio vulnificus, and provides a starting point 
for molecular investigation of previously uncharacterized differences in function. 
Of all seafood-associated human pathogens, none are as critical as those of 
the genus Vibrio, and of all the food-borne pathogens, only infections caused by this 
genus increased (by 78%) between 1996 and 2006[3].  In the United States, a single 
member of this genus, Vibrio vulnificus, causes 95% of all deaths resulting from 
seafood consumption[3].  In addition to the high fatality rate there is a considerable 
level of productivity lost as a result of the symptoms, including nausea, hypotensive 
septic shock, and the formation of secondary lesions on the extremities.  For a human 
pathogen of this importance the molecular data are surprisingly sparse: at the time of 
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this writing three clinical strains of V. vulnificus had been fully sequenced but only 
short read data existed for any environmental strains.  Without a completely 
sequenced environmental strain of V. vulnificus it is not possible to identify the 
genotypic differences that lead to pathogenicity.  In this chapter, we describe the 
sequencing, assembly, and comparative analysis of three environmental strains of V. 
vulnificus.  In addition to identifying the virulence and survival mechanisms that 
contribute to V. vulnificus’s pathogenicity at a genome wide scale, we perform an 
assessment of the sequence assembly process to ensure that genetic content of these 
strains has been captured in its entirety.  
Several approaches have been used to identify genotypic factors that distinguish 
between the virulent and avirulent isolates of Vibrio vulnificus.  Aznar et al. [4] 
identified two groups (termed A and B) of V.vulnificus strains based on 16SrDNA 
gene polymorphism, and Nilsson et al. [5] showed that these two groups were 
associated with clinical (B, or C-type or C-genotype) or environmental (A, E-type or 
E-genotype) isolation.  Despite employing a variety of population genetics methods, 
Gutacker et al. [6]found no association between their grouping and environmental or 
clinical origin.  This contradiction is explained by poor resolution in the traditional 
molecular biology techniques used to identify this pathogen.  Until recently, only 
local genetic differences between two genotypes have been probed, and only the 
genomes of clinical isolates have so far been completely sequenced [7-9].  In 2010, a 
comparative genomic analysis using short read data was performed on four V. 
vulnificus strains, including three environmental strains: 99-520 DP-B8, 99-738 DP-
B5, and ATCC 33149[10].  However, that study employed the ABI SoLID next 
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generation sequencing platform, which produces very short sequence fragments.  
Such reads cannot be assembled ab initio, but must be mapped to the clinical 
reference genomes.  This approach leaves the possibility that regions of the 
environmental genome, for which there are no reference in the clinical genome 
sequence, remain undetected.  By sequencing environmental strain genomes we have 
developed a far more complete understanding of the differences between clinical and 
environmental strains than has previously been possible.  This study also provided us 
with a better understanding of V. vulnificus as an agent of disease and helped to 
identify the molecular components that may be associated with its virulence and 
survival mechanisms. 
1.2        Material and Methods 
1.2.1 Strains, Growth Conditions, and DNA Isolation 
V. vulnificus JY1305 (E-genotype and environmental isolate) was grown 
overnight in Bacto™ Heart Infusion (HI) broth (BD, New Jersey) at 30°C with 
vigorous shaking.  Cells were pelleted by centrifugation and supernatants discarded.  
The cells were washed three times with phosphate buffered saline (PBS) before 
being resuspended to a final approximate concentration of 5×10
8 
cell/ml.  The 
MagMax™ Total Nucleic Acid Isolation Kit (Ambion) and All Prep 
DNA/RNA/Protein Mini Kit (Qiagen) were used for DNA extraction.  The quality 
and quantity of DNA was evaluated spectrophotometrically with the NanoDrop 
ND1000 (Thermo Scientific, Wilmington, DE).  A concentration of 50 ng/µL was 
used for next generation sequencing. 
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V. vulnificus strains E64MW (E-genotype and wound isolate) and JY1701 (E-
genotype and environmental isolate) were grown overnight with shaking in 10 ml of 
alkaline saline peptone water (ASPW).  Cells were pelleted by centrifugation and 
resuspended in 100 µl of ice-cold PBS.  DNA was extracted using DNAzol 
(Invitrogen) according to manufacturer instructions, followed by incubation with 
RNase A.  Subsequently, samples were purified using phenol/chloroform/isoamyl 
alcohol extraction protocol.  Briefly, 40 µl of 3 M sodium acetate was added to each 
DNA sample, followed by 440 µl of pheno/chloroform/isoamyl alcohol.  Samples 
were centrifuged (5 min, 13,000 rpm) and ~400 µl of supernatant was removed and 
mixed with an equal volume of phenol/chloroform/isoamyl alcohol.  This solution 
was centrifuged for 5 min (13,000 rpm) and the supernatant (~200 µl) was subjected 
to ethanol precipitation.  The DNA pellet was re-dissolved in 50 µl 1 ×TE buffer and 
stored at -80°C.  The quality and quantity of DNA was subsequently ascertained 
spectrophotometrically using a NanoDrop ND 1000 (NanoDrop Technologies, 
Wilmington, DE). 
1.2.2 Genome sequencing and assembly 
V. vulnificus JY1305 was sequenced at the Virginia Commonwealth 
University using Roche/454 Titanium technology [11].  One complete sequencing 
plate was used for this genome.  V. vulnificus E64MW and JY1701 were sequenced 
at the BBSRC Genome Analysis Centre (Norwich, UK) also using the Roche/454 
Titanium technology [11].  Quarter plates were used for both.  For all three 
sequencing datasets (JY1305, E64MW, and JY1701) single end reads were 
generated.  De novo assembly with Newbler version 2.3 was initially performed at 
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the sequencing centers [11]. An additional assembly was performed using the MIRA 
3.2.1 de novo assembler[12].  The default parameters for MIRA were used, except 
for the assembly quality parameter, which was changed from “normal” to “accurate”, 
and trace information was excluded from the assembly. 
1.2.3 Genome and gene characterization 
Draft annotation of the sequences was performed using a pipeline of 
published microbial annotation tools, as follows.  Feature determination for each 
strain was performed on the contig set from each sequence assembly.  Feature 
identification methods included Glimmer3.02 (Glimmer) and GeneMark.hmm 
(GeneMark) [13,14].  Both packages are widely used feature determination 
applications whose output is recognized and accepted by NCBI, and both are 
publicly available.  Glimmer was used with default parameters.  An exception was 
that the circular chromosomes were treated as linear in the analysis.  This setting was 
used to prevent each contig from being treated as an individual circular chromosome.  
GeneMark was used with the default parameters.  The models used for training were 
the two V. vulnificus reference organisms (CMCP6 and YJ016).  Spacer sequence 
was added to the ends of each contig to mimic start and stop signals.  The spacer 
sequence was 32 nucleotides in length.  We used the sequence 
NNNNNCACACACTTAATTAATTAAGTGTGTGNNNNN, which is used at the J. 
Craig Venter Institute (JCVI) to merge contigs 
[http://www.jcvi.org/cms/research/projects/annotation-service/submission-guide/]. 
Differences in interpretation may arise when it comes to combining results from the 
various gene identification methods into a unified annotation. Because one of our 
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main goals in this study was to compare the newly sequenced E-type genomes to the 
genome of the previously sequenced C-type strains, we maintained a consistent 
analytical pipeline throughout.  For gene identification in each of the newly 
sequenced strains, one of the following criteria had to be met: (1) A gene will be 
included in the gene list if it can be predicted by either Glimmer or GeneMark, as 
long as the amino acid (aa) sequence length is equal to or greater than 150 aa.  (2) A 
gene must be predicted by both Glimmer and GeneMark to be included in the gene 
list, if its amino acid sequence length less than 150 aa. (3) A gene prediction may 
also be included in the gene list if it occurs in a cluster of known orthologous genes 
found in other Vibrio spp., regardless of whether it meets the length criterion.  A 
cluster is defined as a group of gene sequences that represent either orthologs or 
paralogs from a set of reference genomes closely related to the genome being 
annotated.  The first two criteria were derived from Chen et al. 2003 [6]and were 
used as a consistency benchmark for different gene prediction methods across 
genomes. For the third criterion we defined homology as membership in a set of 
sequences that formed an unambiguous ortholog cluster with all genomes used in 
this study when analyzed using OrthoMCL[15].  
tRNAScanSE was used to predict the tRNAs in the MIRA contigs for each 
strain[16].  RNAHMMER was used to predict the rRNAs from the MIRA contigs for 
each strain[17].  In all cases, default parameter settings were used.  
1.2.4 Gene Clustering 
OrthoMCL version 2.0 was used to cluster newly predicted genes of the three 
newly sequenced environmental V. vulnificus genomes (JY1305, E64MW, and 
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JY1701) with genes from other completely characterized Vibrio spp.[15].  
OrthoMCL uses an all-against-all blastp comparison of sequences as an input step 
followed by application of a Markov clustering procedure.  The e-value cutoff for the 
BlastP algorithm was 1e-5.  Default parameters were used for OrthoMCL except that 
clusters were formed based on a shared sequence similarity of 70% rather than 50%.  
The increased stringency resulted in more constrained gene clusters, and reduced 
inappropriate clustering of partial homologs into ortholog clusters. 
1.2.5 Gene Content Comparison 
The OrthoMCL clustering output that was generated during the annotation 
step became the basis for identification of differentiating genes.  Identified gene 
features and OrthoMCL results were stored in a locally developed OLAP data 
warehouse (GenoSets) that supports queries across aggregate data generated by a 
variety of genomic annotation and comparison methods[18], as described in Cain et 
al.  Annotations for the published C-type genomes were downloaded and parsed 
from the EMBL-Bank public repositories.  Annotations for the novel E-type 
genomes reported were generated as described in section 1.3.4.  Feature boundaries 
were determined from the annotation output and stored, allowing gene presence-
absence queries to be formulated in GenoSets  returning gene features that 
differentiate the three E-types from each other, and from the C-type strains. 
In order to provide a standard means of comparison for feature attributes we 
established relationships between features using two methods.  First, we estimated 
orthologous relationships between genes using OrthoMCL, which uses a Markov 
Cluster algorithm to group putative homologs based on sequence similarity.  
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OrthoMCL has been shown to outperform other stand-alone methods for ortholog 
clustering[15].  For functional analysis, gene features identified in the newly 
sequenced V. vulnificus strains were associated with GO terms using homology 
determined through OrthoMCL clustering of BLASTP results.  For functional 
comparison purposes, we used a controlled vocabulary to describe genes and other 
features.  The Gene Ontology (GO) provides standardized terms for the description 
of gene products in terms of biological processes, cellular location, and molecular 
function [19,20].  If a GO term was associated with any gene within an ortholog 
cluster, all genes within that cluster were also associated with that GO term. 
1.3        Results   
1.3.1 Genome Sequencing and Assembly Statistics 
188,710,063 bases of DNA sequence were generated for V. vulnificus strain 
JY1305. Given the known sizes and expected variability of V. vulnificus genomes, 
we estimated that this is equivalent to ~33x genome coverage depth of the V. 
vulnificus JY1305 genome, of estimated size 5.7 Mb.  We obtained 671,521 reads of 
average length 281 bp of 454-pyrosequencing data for V. vulnificus JY1305.  The 
data were assembled into 159 large contigs and 9,184 unassembled fragments using 
the MIRA assembler, version 3.0[12].  Table 1.1A has the complete assembly results 
for the three E-type strains.  The coverage of each of these genomes is significantly 
above the recommended genome coverage (6-10x) for a whole prokaryote genome 
study established in a recent exhaustive simulation of outcomes of Roche 454 type 
sequencing in prokaryotes[21].  In Figure 1.1, we show the assembled contigs from 
each of the newly sequenced E genomes, aligned to the V. vulnificus CMCP6 
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genome[22].  V. vulnificus CMCP6 was recently re-annotated and is regarded as the 
most complete and accurate of the published V. vulnificus clinical strains 
genome[23].  Assembled contigs were deposited in the NCBI whole genome shotgun 
archive, and are available under project IDS 49015(JY1305), 67135(E64MW), and 
67137(JY1701).  The GenBank accessions IDs are AFSW00000000 (JY1305), 
AFSX00000000 (E64MW), and ASFY00000000 (JY1701) in the NCBI Whole 
Genome Assembly database. 
1.3.2  General Properties of the Vibrio E-type Genomes 
The genome of V. vulnificus JY1305 is composed of 2 circular chromosomes 
with an estimated total of approximately 5.7 MB of genomic DNA.  V. vulnificus 
E64MW is estimated to be nearly identical in size to JY1305.  V. vulnificus JY1701 
slightly smaller at 5.6 Mb.  Some Vibrio strains are known to have plasmids, but the 
V. vulnificus JY1305 sequence data contained no evidence of extra chromosomal 
DNA.  PCR was assays were performed to verify this finding and no plasmid DNA 
(Appendix A) was found in the genomic DNA preps.  It is unknown if V. vulnificus 
E64MW and V.vulnificus JY701 contain plasmid DNA, but no plasmid sequence 
with homology to the known V. vulnificus YJ016 plasmid sequence was identified, 
either in the assembled genomic sequence, or among the unassembled reads. Table 
1.1B summarizes the general characteristics and predicted gene content of each 
sequenced draft genomes.   
1.3.3 Genome Content Comparison 
After annotation of the newly sequence E-genotype Vibrio vulnificus 
genomes described in section 1.3.3, we performed a comparative analysis of the 
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presence or absence of individual genes.  We compared the E-genotype genomes to 
the group of previously sequenced C-genotype V. vulnificus genomes.  Figure 1.2 
summarizes the gene count differentials for the six V. vulnificus strains apart of this 
work.  Genes were clustered together based on the basis of a shared sequence 
similarity of 70% or greater for the purpose of defining orthology, as described in 
section 1.3.4.  The counts represent differential presence or absence of a gene 
ortholog in a given genome. 
1.3.4 The Conserved Core of Vibrio vulnificus 
We identified approximately 3664 orthologs common to all of the V. 
vulnificus strains analyzed in this chapter.  An in-depth comparison between the two 
genotypes of V. vulnificus revealed 278 genes found only in the C-type strains, and 
167 genes found only in the E-genotype strains.  We also identified 43 genes 
common to the three C-genotype blood isolates, CMCP6, YJ016, MO6-24/O, and the 
E-genotype wound isolate, E64MW.  The gene VV2 0404 (vvhA), which is 
commonly used in a core marker set to distinguish V. vulnificus from other Vibrio 
spp. in molecular assays, was found, as expected, in all six V. vulnificus strains, 
which gives us confidence in the sequencing and differential analysis.  The gene 
encoding zinc metalloprotease, VV2-0032 (vvpE), another commonly-used 
diagnostic marker, was identified by Gulig et al. 2010 as being common to both E-
type and C-type strains[10] , and we found this to be true in our analysis, as well.    A 
related gene, VVA0964, the cytolysin secretion protein gene vvhB [24], is unique to 
the V. vulnificus genomes and may have potential as a diagnostic marker.  Also, we 
identified Flp pilus genes common to all the V. vulnificus genomes.  We believe this 
12 
 
is a novel observation, as we have not seen it discussed elsewhere.  The E- and C- 
genotypes of V. vulnificus contain a nearly identical operon for the assembly of an 
Flp pilus, a type IV pilus that mediates adherence, including genes for Flp pilus 
assembly CpaB, CpaC, a conserved unknown protein, and CpaE.  The Tad assembly 
protein of the Flp pilus, including TadA, TadB, TadC, and TadD, are also highly 
conserved and identically ordered in C7184 and YJ016.  Both E- and C- type strains 
of V. vulnificus contain all the components of the Tad assembly proteins except 
TadD, while other Vibrio spp. do not.  These genes may be part of a tad (tight 
adherence) locus, found in a wide variety of bacteria that is characteristic of 
horizontal gene transfer.  tad loci are generally present as part of a mobile genetic 
element, specifically the “widespread colonization island” [25].  Loci such as these 
are known to be related to disease, both human and animal, playing a role in 
colonization and/or pathogenicity.  In non-pathogens, tad loci are proposed to 
facilitate environmental niche colonization[26]. 
1.3.5  Gene and Functionally Different Regions of C- and E- type Isolates 
In Table 1.2 and Table 1.3, we summarize key differences between C-type 
and E –type genomes, listing genes that are shared between the strains of a specific 
genotype, but excluded from the other genotype.  A few of those differentiating 
genes are significance to human virulence or to survival in the estuarine/oyster 
environment.  As in section 1.3.5, features are described using the Gene Ontology 
(GO) categories and terms.  Functional categories having significant enrichment or 
depletion between genomes (at the species or genus level) were identified using the 
Gene Ontologizer[27].   A detailed description of how significance is estimated is 
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given in Cain et al[28].  Figure 1.3 summarizes differences in GO functional content 
between the C-genotypes and E-genotypes of V. vulnificus.  The differential 
functional analysis shows that GO terms mannitol-1-phosphate 5-dehdrogenase and 
N-acetylneuraminidase are significantly enriched in the C-types with an adjusted p-
value of 2.42 
E-04
 and 1.13 
E-05
, respectively.  Specifically, 35% of the genes 
associated with mannitol-1-phosphate 5-dehydrogenase activity and nearly 100% of 
the genes with associated with N-acetylneuraminidase function are found to be 
unique to C-types. Additionally, the GO terms “chondroitin AC lyase activity” and 
“arylsulfatase activity” are significantly enriched with adjusted p-values of 0.0068 
and 0.048, respectively and close to 100% of these genes only found in the C-
genotype strain differentials. In contrast, the E-genotypes appear to be strongly 
enriched in genes associated with the GO functions “urea metabolic process” and 
“nickel ion binding”. Nearly all of the genes that fall under these GO categories are 
only found in the E-genotypes. Both show up as statistically significant differentials 
with adjusted p-values of 1.52
E-09
and 4.37
E-07
, respectively.  E-genotypes also appear 
to have several unique genes that fall into GO categories associated with 
carbohydrate transport and transmembrane transporter activity for a variety of sugars 
and sugar derivatives.  Understanding the overall significance of these genotypic GO 
functional differences will require further investigation. However, we propose that 
these differentiating functional categories may be relevant to the SPANC hypothesis, 
which describes the balance between self-preservation and nutritional competence in 
bacterial genomes [29,30].  Explanation and relevance of the SPANC hypothesis will 
be expanded in section 1.5.1. 
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1.3.6  Genome Sequence Assembly Comparison 
The initial Newbler genome assemblies provided by the sequencing centers 
contained 179, 269, and 269 contigs for JY1305, E64MW, and JY1701 respectively.  
To ensure optimal assembly, we reassembled the sequence reads for each strain 
using MIRA version 3.0[11], which resulted in 159, 274, and 324 contigs for 
JY1305, E64MW, and JY1701 respectively.  Tablet [31]was used to visualize the 
contigs and to investigate the apparent quality of both assemblies.  Figure 1.4 
illustrates the differences between the Newbler 2.3 and MIRA 3.0 assemblies, 
showing a side-by-side comparison of the assembled sequence covering a 
homologous region of a large contig found in both assemblies.  The difference in 
coverage across this region shown in the comparison is typical of the differences in 
assembly results of MIRA 3.0 and Newbler 2.3.  Feature prediction using the 
Newbler 2.3 assemblies resulted in gene undercounts, with 24 apparent genes being 
missed in the JY1305 Newbler assembly, and 63 and 75 genes being missed in 
E64MW and JY1701 respectively.  Newbler left a residue of 9263, 2897, and 2706 
unassembled reads for JY1305, E64MW, and JY1701, respectively, while MIRA left 
9183, 3491, and 3659 reads unassembled for JY1305, E64MW, and JY1701, 
respectively. Based on these observations, we chose to use the MIRA version 3.0 
assembly in all subsequent analyses in this work, and contigs deposited at NCBI are 
from those assemblies.  Table 1.4 summarizes the sequence assembly statistics and 
differences at the initial stage of feature prediction between the two assemblies: 1.4A 
shows MIRA assembly statistics and 1.4B shows Newbler assembly statistics. V. 
vulnificus JY1305 had greater coverage depth, and hence the fewest number of 
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contigs.   The MIRA contigs were of higher quality, as seen in the image below the 
table, which shows an example of a region where the construction quality of a MIRA 
contig is better than the cognate Newbler contig.  This outcome justifies selection of 
the MIRA assembly of JY1305 genome as a reference for subsequent genome 
analyses. 
1.3.7  Gene Retention based on Combined Length and Orthology Criteria 
 We manually reviewed the annotation comparison results to determine 
whether the stringency of our initial criteria for gene inclusion may have caused us to 
miss genes that are found exclusively in the accessory genomes of the E-type draft 
genomes.  The accessory genome is defined as genes that are present in two or more 
strains, but not in all genomes included in the study.  When we simply applied 
criteria similar to Chen et al. 2003 [7] to merge the Glimmer and GeneMark 
annotations described in section 1.3.3, numerous shorter genes were omitted.  
Inclusion of putative genes that were shorter than 150 amino acids in length, but 
were supported by their membership in an ortholog cluster spanning other 
completely characterized Vibrio spp.  added over 700 genes to the gene lists for each 
of the newly sequenced strains.  This increased the number of genes by 21.38%, 
21.39%, and 20.90% for V. vulnificus JY1305, E64MW, and JY1701 respectively.  
Table 1.5 summarizes the predicted gene counts based on these criteria for each of 
the newly sequenced genomes. 
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1.4  Discussion 
1.4.1  Characteristics of E-type Genomes 
V. vulnificus C- and E-type have been shown to exhibit differences in 
pathogenicity and environmental distribution.  In addition, previous examination of 
several housekeeping and putative virulence-associated genes has revealed a number 
of genetic polymorphisms suggesting that these two genotypes are in the process of 
diverging into distinct ecotypes [32,33].  One hypothesis of particular interest, 
referred to as the SPANC (self-preservation and nutritional competence) balance, 
could potentially offer insight into the niche adaption and differentiation seen in V. 
vulnificus C- and E-genotypes.  The SPANC hypothesis has been well characterized 
in E. coli and demonstrates that clonal populations can experience genetic mutations 
and phenotypic changes as a result of physiological stress under conditions such as 
nutrient starvation.  These changes often lead to variations in the activity of the 
global gene regulator, sigma factor (rpoS), which governs the general stress 
response.  Decreased RpoS activity can lead to the development of specialized 
populations which are less resistant to stress but have broader nutritional capabilities 
and a higher affinity for low nutrient concentrations, whereas the original population 
is more stress tolerant but less nutritionally competent[29,30].  In aquatic 
environments, in which nutrients are often limiting and competition for resources is 
intense, such modifications could confer a selective advantage for these bacterial 
strains. 
It seems plausible that this trade-off between self-preservation (stress 
resistance) and nutritional competence could be a factor driving the diversification of 
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V. vulnificus species.  By completely sequencing three E-genotypes of V. vulnificus, 
we were able to identify those genes that are specific to E-genotypes.  As noted in 
the section 1.3.5, the GO functional differences in gene content between C- and E-
genotypes show that the sequenced E-type genomes are significantly enriched for 
metabolic functions such as urea and nitrogen cycle metabolism, suggesting that the 
E-genotypes may possess more versatile metabolic capabilities.  Laboratory studies 
support this finding demonstrating that when V. vulnificus C- and E-genotypes are 
grown in co-culture, E-genotypes are favored under nutrient rich conditions (Rosche 
and Oliver, unpublished).   
Coping with the rapid host transition, from oyster to human likely requires a 
variety of stress resistance genes, both protective and adaptive.  Previous studies 
have demonstrated the need for stress regulators for adaption to conditions of  
starvation, osmotic stress, low pH, non-optimal temperatures, and oxidative 
damage[34].  Studies investigating the ability of V. vulnificus to survive stressful 
conditions have shown that C-genotypes are significantly better able to survive in 
complement-activated human serum than E-genotypes[35].  Rosche et al. 
demonstrated that C-genotypes exhibit better cross-protection when exposed to 
multiple stresses, such as osmotic shock followed by H2O2 exposure or elevated 
temperature[33].  Under conditions tested to date, C-genotypes appear to be 
physiologically more stress tolerant, and this suggests that the SPANC hypothesis 
may apply in Vibrio vulnificus, in that C-genotypes are more capable at self-
preservation, while E-genotypes carry additional genes that suggest they may be 
more capable of nutritional competence. Sequence alignments of the rpoS gene for 
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all six sequence strains did not indicate any major genetic polymorphisms, with only 
a few amino acid substitutions.  The nucleic acid sequence is ~99% identical and the 
coded protein 98.5% identical.  Other genes that may affect the SPANC balance 
[34]are similarly well conserved. Future studies will need to be performed to 
investigate the roles of E- genotype specific genes under relevant conditions such as 
nutrient limitation in order to validate this hypothesis. 
1.4.2  Characteristics of C-type Genomes 
Mannitol transport and fermentation genes were found to be present in the C-
genotype strains but not in the newly 3 sequenced E-genotype strains.  Mannitol has 
been correlated with virulence-associated genotypes (vcgC and 16S rDNA type 
B)[25]. This lack of a mannitol operon (consisting of a dehydrogenase, a 
phosphotransferase system component, and an operon repressor) in the sequenced E-
type strains was identified in a previous study[37,38]. This differentiating feature 
was also identified in a recent analysis of short-read sequence fragments from four 
other E-type strains[10].  It is important to note that while many E-genotype strains 
lack the mannitol operon, phenotypic and molecular testing by the Oliver laboratory 
at the University of North Carolina at Charlotte has shown that 40% of 73 total tested 
E-type strains in their study contained the mannitol operon and were able to ferment 
this sugar[37,38].  The strains sequenced in this study and in the study by Gulig et al. 
[10]were among those previously known, before sequencing, to be unable to ferment 
mannitol, and future sequencing should include E-genotype strains that are able to 
ferment mannitol, to provide a more extensive comparison between these two 
phenotypes. 
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Cohen et al. (2007) used multi-locus sequence tag (MLST) data to identify a 
33-kb genomic island (region XII) on the second chromosome of V. vulnificus [37].  
This region contained an arylsulfatase gene cluster, a sulfate reduction system, two 
chondroitinase genes, and an oligopeptide ABC transport system, none of which 
were found in their “lineage II” (our E-genotype) isolates. They suggested that this 
region may play a role in the pathogenic process, as both arylsulfatases and the 
chondroitin sulfate proteoglycan degrading chondrotinase have been speculated to be 
involved in the penetration of epithelial cells[40,41].  The authors thus speculated 
that region XII, along with others, could give members of the C-genotypes a 
selective advantage in their relationships with aquatic environments or human hosts, 
or both.  Gulig et al. (2010), in their V. vulnificus sequencing study, suggested that 
the ability to scavenge sulfate groups could facilitate survival in the human host, 
where free sulfur is limited[10].  Cohen et al. (2007) identified region XII in 32 of 
the 37 lineage I genotypes included in their study are the  C-genotypes, V. vulnificus 
CMCP6, V. vulnificus MO6-24/O and V. vulnificus YJ016 , but in only 3 of the 6 
lineage II strains[39].  Consistent with their findings, we identified 83.3% of the XII 
region as being present only in the C-genotypes (YJ016, CMCP6, MO6-24/O), and 
not in the three newly sequenced E-genotypes. 
Type IV secretion system gene VirB4 (VV2_0638) was found to be present in 
C-genotype strains (V. vulnificus YJ016 and V. vulnificus CMCP6) but absent in the 
newly sequenced E-genotype isolates and V. vulnificus MO6-24/O.  Type IV 
bacterial secretion systems (T4SS) are responsible for the translocation of molecules 
such as DNA, proteins, and toxins out of the cell and into the immediate 
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environment or the host cell[42,43].  This system is composed of the T-pilus and 
membrane-associated complex and is constructed from 12 VirB proteins, several 
other Vir proteins, and a coupling protein (VirD4) [43,44].  Of these proteins, VirB4 
serve as a energizing component as this gene has been  associated with ATPase 
functionality[44,46]. Because this system is associated with the transfer of DNA 
(conjugation) and also toxins, it is also often implicated with pathogenicity. Our V. 
vulnificus E-genotype strain sequencing suggests that these T4SS components play a 
role in infections caused by C-genotypes (V. vulnificus YJ016 and V. vulnificus 
CMCP6). 70% of the predicted virB operon sequence of the T4SS has been observed 
to be present in the C-genotypes (V. vulnificus YJ016 and V. vulnificus CMCP6) and 
not in M06-24 or the E-genotypes [47].  Sequencing of more C- and E-genotypes 
should be performed to investigate whether the presence of this operon displays a 
trend towards virulent strains in Vibrio vulnificus. 
1.4.3  Assessment of Genome Assembly and Identification  
 Genomic assembly and feature prediction assessment metrics are based on a 
numerical scale.   Lower contig counts, higher gene prediction counts, and high N50 
values are ideal in constructing high-quality draft genomes.  N50 is defined as the 
size of the contig that represents 50% of the assembled genome.  Smaller contig 
counts are used as an indicator that fewer gaps were constructed when assembling 
the genome, which can be interpreted as a higher probability that the genome is 
complete.  The more complete the genomic sequence, the higher our confidence that 
the gene content has been completely captured for the newly sequenced organism.  
In this work we used comparative  approaches to select the best assembly to use for 
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the E-type genomes to use on our comparative genomic analysis. By re-assembling 
the sequence read fragments for V. vulnificus JY1305 with an alternative de novo 
assembler, we constructed an improved draft genome based on decreased contig 
counts and increased gene prediction counts. This workflow was also applied to V. 
vulnificus E64MW and JY1701, even though the available data for these genomes 
led to slightly higher contig counts with MIRA than in the original Newbler 
assemblies.  However, as noted above, gene counts were corrected by substantially 
improved.  Baker et al. 2012 [48] stated that the bioinformatics community still 
struggles with next generation sequencing data and analysis; in part this is because 
benchmark data sets and algorithms are not available.  An even greater problem is 
that the majority of the microbial comparative genomics studies do not include their 
bioinformatics analysis steps in sufficient detail to replicate the analysis process, so it 
is uncertain what precautions were taken to ensure that genetic components were 
captured.  In this work we have taken care to produce complete computational 
workflow details, allowing others to identify the same genetic components in these 
genomes.  By performing multiple assemblies and gene prediction methods we are 
able to validate our computational measures and identify unknown genetic 
characteristics with confidence. As additional sequencing data is obtained, for 
example to fill gaps and finish these genomes, only minor changes in differential 
gene list should result if the same pipeline is used. 
1.5  Conclusion 
Three E-genotype strains of Vibrio vulnificus have been sequenced to over 
99% completion.  The genomes have been assembled using ab initio methods and 
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contig sequences have been deposited in the NCBI Whole Genome Shotgun archive.  
We expect this effort to provide insights into structural rearrangements among the C-
genotype and E-genotype strains, but we do not expect additional sequencing to 
significantly alter the membership in the list of strain-differentiating genes reported 
in this chapter.  The presence or absence of a particular gene in a specific genotype 
provides an initial target for functional differentiation.  This work also provides the 
V. vulnificus community with a valuable reference for functional study of 
determinants of virulence, survival, host-specificity and adaptation, and facilitates 
the use of high-throughput approaches to assess the functional differences via the 
study of the V. vulnificus transcriptome and the possibility to investigate the 
evolutionary event or series of events that led to the environmental niche 
specification seen among the V.vulnificus genotypes.  
Also in this chapter, we began to investigate the types of  metrics used to 
evaluate the quality of a draft genome and its annotations and the steps that can be 
taken to determine that they are sufficiently accurate and complete to capture the true 
genetic make-up of an organism. We showed that combining ab initio gene 
predictions and comparative information we can identify and interpret gene content 
in a comparative genome analysis.  In chapter 2, this analysis is expanded to include 
approaches to benchmarking when a reference genome is available, and to 
systemically test the outcomes of different workflow choices in microbial genome 
assembly and annotation. 
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FIGURE 1.1: Vibrio vulnificus biological classifications. Biotype 1- primarily associated 
with human death, Biotype 2 – primarily pathogen of marine organisms, and 
 Biotype 3- to date only reported in wound infections.  C-genotype – strains 
 isolated from clinical sources, most commonly found in human infections and  
 E-genotype – strains isolated from environment, rarely cause human disease. 
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FIGURE 1.2 Circular maps of the sequencing contigs of V. vulnificus JY1305, E64MW, 
 and JY1701.From the outside in, the first circle (red) represents V. vulnificus JY1305 
genomic contigs, the second circle (green) represents V. vulnificus JY1701 genomic 
contigs, and third circle (blue) represents V. vulnificus E64MW genomic contigs. 
The circles represent BLAST alignment of contigs against the V. vulnificus CMCP6 
reference genome. Circle 4 shows GC content. Figure generated using CGView. 
 
 
  
Chr .1 
Size: 3.8 Mb 
Chr .2 
Size: 1.9 Mb 
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FIGURE 1.3: Vibrio vulnificus genomic content differential Venn diagram. 
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FIGURE 1.4:  Gene Ontology (GO) functional differences between 
 C- and E- genotypes.Figure shows GO functional categories which are enriched in C-
genotypes of V. vulnificus relative to E-genotypes (blue) or E-genotypes relative to C-
genotypes (red). Percentages represent percent of genes under each category that are 
differential between the genotypes. Percentages of less than 20% are not depicted. 
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FIGURE 1.5:  Homologous sequence contig comparison between  
MIRA 3.0 and Newbler 2.3. 
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CHAPTER 2: IMPACT OFANALYTIC PROVENANCE IN GENOME ANALYSIS 
 
 
2.1  Introduction 
 Comparative genomics studies are executed on the premise that completely 
characterized and closed reference genomes are used to represent the organisms in the 
analysis.  However, since the development of the next generation sequencing (NGS) 
technologies, it is more common in microbial comparative genomic studies for 
incomplete or draft genomes to be used.  The majority of newly sequenced bacterial 
species do not have a closely related species completely sequenced and characterized, 
making reference-based methods inappropriate to construct their genome.  The 
weakness of reference-based assembly is that it cannot accurately represent regions of 
which there is no equivalent sequence in the reference. These differentiating regions 
are often the regions of greatest interest in a comparative genomics study.  In the case 
of Vibrio vulnificus two different reference genomes exist, and currently there is not a 
quantitative way to select which reference genome would be the most appropriate to 
use in assembly of the newly sequenced genomes.  When a newly sequenced genome 
cannot be assembled based on a reference sequence, de novo assembly and ab initio 
gene finders are used.  
There are many computational tools for de novo assembly and ab initio gene-
finding on next generation sequencing data.  Both of these stages in a genome project 
are vital for accurate interpretation of genomic data in a comparative genomics study. 
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Ab initio gene-finders use signal or pattern recognition techniques based in 
known prokaryotic gene features to identify probable genes.  However, gene-finders 
are very sensitive, both to parameters and training sets used within the application 
itself, and to the methods chosen to construct the underlying genome that is being 
annotated.  This chapter focuses on the de novo assembly and ab initio annotation of 5 
newly sequenced V. vulnificus strains.  An automated pipeline approach was used to 
exhaustively test combinations of methods and parameters at the assembly and 
annotation stages.  The outcome of the comparative genomics study, including 
identification of enriched gene function categories that often point the way to gene 
candidates for further molecular investigations, are heavily dependent on the analysis 
workflow, and a benchmarking approach is recommended in order to establish the 
optimal approach. 
2.2 Background 
Many computational methods are available for assembly and annotation of 
newly sequenced microbial genomes.  However, when new genomes are reported in 
the literature, there is frequently very little critical analysis of choices made during the 
sequence assembly and gene annotation stages.  These choices have a direct impact on 
the biologically relevant products of a genomic analysis – for instance identification of 
common and differentiating regions among genomes in a comparison, or identification 
of enriched gene functional categories in a specific strain.  That is, there are 
consequences both for biological and clinical relevance of the results in terms of 
accuracy and completeness (or sensitivity and specificity).  Inconsistencies arise from 
the algorithms selected, the parameters used in those algorithms, and the order in 
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which operations are carried out.  The impact of such inconsistencies is multiplied 
genomes to be compared are analyzed with different workflows.  Tracking the analysis 
history of the data – its analytic provenance – is critical for reproducible analysis of 
genome data.  Here, we examine the outcomes of different assembly and analysis steps 
in typical workflows, using as a data set the comparison of assembly and features 
across strains of Vibrio vulnificus. 
Next generation sequencing (NGS) has revolutionized the study of microbial 
genomics, by making the data required to complete a genome available within days.   
The bottleneck has thus moved to the analysis stage of the experiment. To handle the 
millions of sequence read fragments produced by the NGS platforms, a variety of 
assembly approaches have been developed [49-51].  In most instances the assembler 
produces a set of contigs or scaffolds, which still leaves the genome in dozens to 
hundreds of pieces.  Until a group adopts the organism for full analysis it is no longer 
common to completely finish or close a newly sequenced genome. Usually, we 
evaluate the “success” of the draft assembly with two metrics: the number of contigs 
produced and the N50 value.  Lower contig counts and higher N50 values are 
considered optimal.  N50 is defined as the size of the contig that represents 50% of the 
assembled genome.  A contig is a consensus of overlapping DNA sequencing reads 
that represent a region of the newly sequenced organism’s DNA.  However, Parra et 
al. [52] and others[48] reported that choosing assemblies with higher N50 values 
frequently results in conserved genes going undetected in benchmark studies. If a gene 
sequence is omitted due to errors at the assembly stage it will not be annotated, 
leading to inconsistencies in downstream analyses. 
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There have been several efforts to assess the quality of assemblies produced by 
de novo methods. De novo assembly is defined as assembling DNA sequencing reads 
without the aid of a reference genome.  The GAGE [53] and the Assemblathon [54] 
projects provided gold-standard data sets and a consistent environment for peer 
evaluation of assembly methods.  Recently, NGS read assemblers were evaluated 
using bacterial datasets in the GAGE-B study.  Magoc et al. [55] showed that a single 
library prep and deep (100x -250x) sequencing coverage is sufficient to capture the 
genomic content of most bacterial species, but from the same base data demonstrated 
that there is wide variation in the final assemblies produced by different methods. 
Analysis of genomes does not stop at assembly, however.  There exists a wide 
range of methods for finding features, or annotation of the assembled data.  Genome 
annotation includes identification of the gene sequences within a contig, and 
assignment of function based on similarity to known genes or sequence patterns.  Ab 
initio gene finders and methods for functional assignment each have their own 
associated assumptions and errors, and results from one method are unlikely to agree 
completely with those from another [48].  Assembly and annotation are the two major 
components of the bacterial genomics workflow, and there are an astonishing number 
of combinations of methods that can be used to carry out just these two steps. 
When we survey the literature in microbial genomics, we find that 
investigators depositing microbial sequences have not come to a consensus on the best 
pipeline for genome analysis.  Several different assemblers are in common use.  
Annotation methods may include anything from simply comparing the genome to a 
reference by using BLAST, to using ab initio genefinders, to using integrated 
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annotation pipelines provided by sequencing centers.  Despite over a decade of 
literature on the performance of ab initio genefinders and annotation pipelines, [56-59] 
nearly any reasonable workflow seems able to pass peer review (Figure 2.1), and so 
the genome annotations found in the public databases vary widely in analytic 
provenance.  Especially in the absence of ground truth, the proliferation of analysis 
options can lead to inconsistencies (comparing apples to oranges) and ultimately to 
errors in biological interpretation.  It is not possible to distinguish a true target, such as 
a gene that differentiates one genome from its near relatives, from an artifact 
introduced at the assembly or annotation steps.  Yet investigators often seem to remain 
unaware of the impact of their choices, and how the selection of Glimmer[13] rather 
than GeneMark[14] (for example) may result in a greatly altered story when they 
begin to analyze the apparent content of a newly sequenced genome.  Figure 2.1 is a 
summary of the major elements of current genomic workflows based on a census of 
2013 bacterial genome announcements in recent issues of the journal GenomeA 
(American Society of Microbiology)[60]. 
In this study, we assess the scope of the data interpretation problem caused by 
variation in pipeline choices.  Starting with five V. vulnificus strains for which paired-
end Illumina sequence was collected by the laboratory of Dr. Craig Baker-Austin 
(personal communication), and one V. vulnificus genome with a high quality finished 
sequence that has been continually revised and updated[23], we apply well-regarded 
assembly and annotation methods, in different combinations, to the data.  We have 
chosen to focus on the most popular methods in each category, because workflow 
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construction from multiple options is a combinatorial problem, and not all 
combinations make sense. 
The case study data demonstrate the influence of choices made during the 
assembly and annotation stages on biological interpretation of newly sequenced 
genomes.  Vibrio vulnificus is a bacterium commonly found in estuarine waters and 
mollusks.  It is responsible for 95% of all deaths resulting from seafood consumption 
in the United States[3].  There are both clinical isolates and environmental genotypes 
associated with this bacterium, making it a prime candidate for a clinically relevant 
comparative genomics study.  In the present study, we demonstrate the direct impact 
of parameter and method choices on the output of a comparative genomics analyses 
among newly sequenced strains of Vibrio vulnificus.  The results highlight the need for 
contributors of genomic data to provide complete information about the workflow 
(analytic provenance) of their assembled and annotated genomes as they do for library 
preparation steps, and for application of consistent workflows, justified by benchmark 
testing where possible, to be used throughout a project. 
2.3  Material and Methods 
2.3.1  Genome Sequencing and Sequencing Simulation 
V. vulnificus strains were sequenced at The Genome Analysis Centre (TGAC) 
using the Illumina HiSeq2000 platform.  Sequencing was carried out on pooled 
libraries, using pools of 12 strains in one lane of the Illumina HiSeq 2000, and 
producing on average 100 base pair (bp) paired-end (PE) reads.   V. vulnificus CMCP6 
chromosome 1 and 2 genome sequences were used to construct a simulated data set of 
100 bp PE reads.  The simulated read (SR) set was constructed with ART version 
1.5.0 using the program art_illumina[61].  The simulation parameters used were as 
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follows: data type “paired end”, read length  “100”, fold coverage “100”, and quality 
score “20” (forward and reverse sequence reads).  This dataset was used as a 
benchmark to evaluate the performance of the de novo assemblers, gene prediction 
algorithms, and annotation methods to reproduce the published sequence and 
annotations of the CMCP6 genome. V. vulnificus CMCP6 was recently re-annotated 
and is regarded as the most complete and accurate of the published V. vulnificus 
genomes at the time of this writing. 
2.3.2  Data Cleansing  
 FastQC was used to evaluate the quality of the sequence reads for each 
strain[62].  Any repetitive sequence identified by FastQC was removed from the 
dataset using an in-house perl script.  If a sequence read contained 1 or more ‘N’, both 
the read and its pair were removed.  After the data-cleansing steps were completed we 
sampled a subset of reads for each strain that was equivalent to 100x coverage based 
on the Lander and Waterman statistic[63].  After the data-cleansing steps were 
completed each newly sequenced isolate read set contained 11,400,000 paired reads.  
In the case of V. vulnificus CMCP6, the ART sequencing simulation program art-
illumina generated 6,620,286 paired reads for CMCP6 using an identical threshold.  
This difference may be due to use of an alternative mathematical formula for 
calculating genome coverage in ART. 
2.3.3  Sequence Assembly 
 Initially, each read set was assembled with VelvetOptimiser version 2.2.0 and 
Velvet 1.0.17 in order to identify an optimal kmer value for assembly and construct an 
initial contig set.  A kmer value is used in a de novo assembly to set a minimum length 
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on the number of contiguous nucleotides that should overlap to construct a contig 
sequence. The optimal kmer values were 79 for V. vulnificus CIP8190 and CECT5763, 
83 for V. vulnificus CMCP6 and 87 for V. vulnificus CECT5198, CECT4606, and 
CECT4886. The VelvetOptimiser parameters were then used to initiate the Velvet 
assembler.  The VelvetOptimiser hash value (kmer) was set to a range of 73 to 93. The 
read description parameter was set to “-shortPaired”.  The VelvetOptimiser optimal 
kmer value was also used as the input kmer value for ABySS version 1.2.6 (abyss-pe) 
and SOAPdenovo version SOAPdenovo127mer.  The default paired-end parameters 
were used for both assemblers. 
2.3.4  Contig Comparison 
MUMmer 2.3 was used to create sequence alignments between assembled 
contigs, within collections of assemblies for the same genome and among genomes. 
2.3.5  Genome Annotation 
 Ab initio gene-finding and functional annotation for each contig set was 
performed using the in-house workflow microbial assembly and annotation pipeline 
constructed in the Taverna workflow management system [64].  This workflow 
executes parallel assembly-to-analysis pipelines on a genomic data set. The ab initio 
annotation methods implemented include Glimmer3.02, GeneMark.hmm and the 
Rapid Annotation using Subsystem Technology (RAST) [65] web service.  The 
training model used for ab initio gene finding with Glimmer and GeneMark was 
constructed based on published Vibrio vulnificus annotations available in the NCBI 
database.  The RAST web service parameters used were as follows: the genetic code 
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was set to 11 for bacteria, taxonomy id was set to 672 for genus Vibrio, and the 
corresponding sequencing statistics for each strain were provided to the web service. 
2.3.6  Ortholog Identification and Functional Annotation 
OrthoMCL[15] was used to cluster gene predictions with reference genes in 
the Vibrio vulnificus CMCP6 genome. For this application a cluster threshold of 95% 
identity was used. OrthoMCL[15] was also used to make connections between 
orthologs among sequenced Vibrio vulnificus strains, with a clustering threshold of 
70% identity.  Gene ontology (GO) terms were assigned using the BLAST2GO 
software [66].  BLAST2GO was used to perform a BLASTP against the nr (non-
redundant) protein database, with e-value cut-off set to 1
E-6
. GO annotations were 
assigned based on the BLAST2GO database version b2g_mar13.  BLAST2GO assigns 
GO terms based on a weighted system of evidence codes. 
2.3.7  Content and Functional Comparison 
 For comparison of assembly-to-annotation workflow outcomes and for 
comparisons of genomic content, we used the GenoSets software application[18]. The 
annotations produced by each workflow were loaded into the GenoSets application, 
which enables comparisons among multiple genomes. Each alternate annotation was 
treated as a separate “genome” in the GenoSets system.  We followed the same gene 
clustering procedure used in Morrison et al. 2012 [2] to define sets of genes that 
differentiate between genomes. To differentiate between the assembly-to-analysis 
pipeline outcomes, the approach was modified to reflect the expectations that gene 
sequences arising from different analysis workflows would be highly similar. 
OrthoMCL clustering was performed against the Vibrio vulnificus reference genome 
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CMCP6 and clusters were formed based on a shared sequence similarity of 90%, 
instead of the OrthoMCL default parameter of 50%.  The increase in stringency to 
90% shared sequence similarity results in tightly constrained gene clusters, and allows 
for the possible of identified genes on the ends of contig that may have not been 
predicted in their entirety. 
2.4  Results 
2.4.1  Workflow Dependent Outcomes in Simulated Assembly Case 
As a basis for choosing an appropriate analysis pipeline for newly sequenced 
V. vulnificus genomes, we first generated simulated read data from the genome of V. 
vulnificus CMCP6.  This genome was initially sequenced using Sanger sequencing 
and a traditional genome finishing approach in 2003, [8] and was updated with revised 
annotation in 2011[23].  The published sequence and annotations served as ground 
truth for evaluation of pipeline options. 
We performed de novo sequence assemblies of the simulated data with Velvet 
(V), ABySS (A), and SoapDenovo (S).  GeneMark.hmm (GeneMark)[14] and 
RAST[65] were then used to identify gene sequences for each contig set.  We used 
OrthoMCL[15] with a stringent similarity cutoff to cluster predicted genes with their 
counterparts in the 2011 V. vulnificus CMCP6 annotation. 
 The contig counts observed were 205, 144, and 269 for the V, A, and S 
assemblies, respectively.  Table 2.1 summarizes gene counts obtained for each 
assembly followed by each gene annotation method, for the simulated V. vulnificus 
CMCP6 genomes. To avoid ambiguity, the percentage of genes recovered refers only 
to predicted genes, which clustered uniquely with one gene in the reference 
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annotation.  Less than 1% of predicted genes cluster with apparent paralogs in the 
reference genome when clustered at a 95% threshold.   
The results presented in Table 2.1 suggest that, while the Velvet assembler[49] 
does not assemble the simulated data into the smallest number of contigs, it produces 
the most accurate assembly of the simulated V. vulnificus CMCP6 data.  Velvet, in 
combination with the GeneMark[14] ab initio gene-finder, may produce the best 
results on novel V. vulnificus sequence data.  This type of simple two-step workflow is 
representative of genome analysis workflows found in the genome announcements 
surveyed in Figure 2.1.  However, it should be noted that the best-performing 
workflow still resulted in a loss of over 200 previously annotated genes, when 
reanalyzing simulated V. vulnificus CMCP6 data. 
2.4.2 Workflow Dependent Outcomes on Novel Genome Data 
 The published Vibrio vulnificus genomes are mainly composed of 2 circular 
chromosomes, and some are known to have plasmids.  The size of the V. vulnificus 
genome is estimated at 5.6Mb-5.8Mb of DNA, and this size is consistent among 
known strains.  The newly sequenced isolates V. vulnificus CIP8190, CECT5198, 
CECT4606, CECT5763, and CECT4886 are all known to have 2 chromosomes and 2, 
3, 1, 2, and 2 plasmids, respectively.  Table 2.2 describes each genome used in this 
study and its genomic characteristics, as well as the number of sequence reads 
available for each genome. 
Our analysis here is primarily focused on the performance of the assembly and 
annotation steps typically used during the construction of a draft genome.  Biological 
findings for these genomes will be the focus of another manuscript, currently in 
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preparation.  Using the workflow framework shown in Figure 2.2, we assembled 
contig sets and annotation sets for each V. vulnificus strain.  After the removal of 
sequence reads containing ‘N’ characters, and random sampling of read pairs to obtain 
100x genome coverage based on the Lander Waterman statistic[63], there were 
11400000 paired end reads in the final read sets for each of the newly sequenced 
strains.  The same coverage depth was simulated for V. vulnificus CMCP6. 
 Using the same de novo assemblers we applied to the simulated data set, we 
constructed contig sets ranging in size from 180-630 contigs for each of the input 
genomes.  Table 2.3 summarizes the output of Velvet, Soap, and ABySS assemblies 
for each V. vulnificus strain.  We then used MUMmer 2.3[67] to align the contig sets 
for each strain, using an all-against-all alignment to identify contigs that were 
similarly constructed between the assemblers.  Contig pairs that exceeded coverage 
and sequence identity cut-offs of 95% were identified as similarly constructed.  Figure 
2.3 summarizes the conservation of contigs across assemblies.  Although counts varied 
from genome to genome, we observed on average 43 contigs constructed by all three 
assemblers, 133 found by any combination of two of the three assemblers, and 445 
contigs that were uniquely constructed by a specific assembler. 
 In our analysis of the novel Vibrio vulnificus genomes, we included the 
Glimmer3.0[13] ab initio gene-finding method in addition to GeneMark[14] and 
RAST[65].  Glimmer3.0 is demonstrated to be approximately 96% accurate in gene 
identification, [13] which is similar to the accuracy that we observed for GeneMark in 
the CMCP6 case study above.  In Table 2.4, we summarize the gene predictions by 
each of the three prediction methods for each of the three assemblies constructed for 
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each V. vulnificus strain.  We find that RAST and GeneMark tend to identify more 
regions as putative genes sequences than Glimmer for these strains. However, this is 
not a case of simple over-prediction, since the Glimmer gene sequences are not strictly 
a subset of the predictions by other methods.  As an example, in Figure 2.4 we detail 
the number of gene overlaps between all possible assembly-to-annotation 
permutations for V. vulnificus CECT4606. 
Figure 2.5 summarizes the gene overlaps for Vibrio vulnificus CMCP6 and 
CECT4606 datasets for different genefinders applied to assemblies generated by the 
Velvet assembler.  Gene overlaps are defined as two genes that have the same start 
and stop signals and strand orientation on the same contig sequence. This is a stringent 
definition of similarity among predictions.  Glimmer tends to predict fewer genes that 
are outside the common “core” of predictions produced by all three genefinders.  It is 
possible that this reflects greater accuracy, or it may be that Glimmer alone is more 
conservative in its gene-identification model. RAST (which uses Glimmer in an initial 
annotation pass) and GeneMark both make, and agree upon, predictions that are 
excluded from the Glimmer prediction set. It is possible that these two methods are 
potentially capturing more species-specific genes. 
2.4.3 Workflow Dependent Outcomes in Functional Analysis 
 An archetypal result presented in genomic analyses is the categorization of 
genes into functional categories. This type of analysis is frequently used to draw 
conclusions about the energy sources an organism can use for survival, or about the 
genome’s capacity to code for systems related to pathogenicity. To illustrate the 
impact of workflow choice on interpretation of functional content, we performed a 
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comparative analysis among the results of six assembly-to-annotation workflows 
applied to the genome of V. vulnificus CECT4866. We used the GenoSets analysis 
system to perform the comparison of analysis outcomes, treating the annotation set 
produced by each workflow as if it were an independent “genome”.  
Each workflow’s gene set was assigned Gene Ontology (GO) terms[19,20] as 
described in Cain et al., 2012[28].  GO categories and individual genes having 
functionality significant enrichment or depletion between the various annotation 
versions were identified using the Gene Ontologizer[27].  Table 2.6 summarizes the 
complete GO enrichment set for each of the workflow combinations examined. We 
first compared annotations produced by a workflow that used the Velvet assembler, 
followed by either Glimmer or GeneMark.  134 genes appeared in the Glimmer 
predictions, but not in the GeneMark predictions, resulting in the appearance of 
statistically significant enrichment or depletion in two GO functional categories.  
Deoxyribose phosphate metabolic process and deoxyribose phosphate catabolic 
process p-values were 0.0066 and 0.0072, respectively. 120 genes were identified 
solely with GeneMark annotations. Use of GeneMark resulted in the appearance of 
enrichment in GO terms associated with response to stress and iron ion binding, with 
p-values at 5.99
E-12 
and 0.0017, respectively. The GO terms associated with iron 
utilization are especially of interest in the context of Vibrio vulnificus genomics, 
because as a pathogen it is especially dangerous to hosts in a condition of iron 
overload[68].  Iron-protein binding and stress response are potentially regarded as 
factors contributing to V. vulnificus’s pathogenicity. Several studies have reported on 
the correlation between V. vulnificus infections and increased levels of iron in animal 
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models and infected individuals [3,68,69].  Wright et al.[68] showed the injecting 
mice with iron prior to V. vulnificus infection significantly lowered the LD50.   Amaro 
et al. [69] showed that after the injection of V. vulnificus to an iron-overload mice, 
they always died within a 48 hour period of inoculation. In this case, changing the 
assembly-to-annotation analysis pipelines result in a significant change in detected 
gene content, in a category that is directly relevant to the biology of the pathogen. 
We next examined pipelines using the ABySS assembler followed by RAST or 
Glimmer. 1880 genes were unique to the RAST annotation. Of these, 132 significant 
GO enrichment terms were identified. In this set we find both iron-binding protein and 
terms associated with response to stress, again suggesting that the choice of assembly-
to-annotation pipeline has the potential to significantly alter biological interpretation.  
Only 148 gene clusters were unique to the Glimmer set, and only 5 functional 
categories showed apparent statistically significant enrichment.  Comparison of RAST 
and GeneMark annotations on a SOAPdenovo assembly resulted in approximately 10 
statistically significant differences in functional content in either direction, although 
none of these categories were identified as significant to the biology of V. vulnificus in 
a previous study[2]. 
While these results are not conclusive, they indicate that at least in the case of 
V. vulnificus, RAST or GeneMark predictions may best reflect the presence of genes 
in key functional categories, known to be significant in the biology of these organisms. 
2.4.4 Workflow Dependent Outcomes in Genome Content Comparison 
 Another archetypal figure found in nearly every comparative genomics 
analysis paper is the Venn diagram or its conceptual equivalent. The Venn diagram 
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provides a convenient method to summarize what the microbiologist really wants to 
know:  what is in strain (or species) A that makes it function differently from strain B? 
In Figure 2.6, we show the effect on this commonly generated analysis product when 
different assembly-to-annotation pipelines are used to generate the input data. As an 
illustrative example, we performed gene content comparisons between V. vulnificus 
strain CMCP6 (clinical genotype) and strain CECT5198 (environmental genotype). In 
each comparison, the same assembly-to-annotation pipeline was used on each of the 
genomes being compared.  We tested four combinations of assembler and gene-finder.  
In Figure 2.6, we show that the majority of differences are seen when different 
annotation methods are used. In contrast, when different assemblers are used with the 
same annotation method, the number of differential genes is highly conserved. Given 
the large number of non-identical genes found when different pipelines are used on the 
same genome, as we saw in the previous examples, the result is as expected – the 
valuable biological “end product”, the set of differentiating genes around which the 
biologist will build their scientific conclusions, can vary by dozens if not hundreds of 
members.   
2.5  Discussion 
Many factors can have an impact on the assembly of next generation sequence 
data. Typical information captured about the provenance of sequence data focuses on 
laboratory procedures and conditions, as we see in the MIGS standard for genomic 
data[70], or in the experiment information preserved in, for example, the NCBI’s Gene 
Expression Omnibus[71]. However, assuming that samples were properly handled and 
prepared in the laboratory and those procedures and conditions are consistent, there is 
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still an entire layer of provenance information to be considered.  Here, we have 
considered the analytic provenance of genome sequence data, that is, the 
computational steps that are executed to process the data and to attach features and 
functional information that allows for interpretation. 
Despite an attitude on the part of researchers and publishers that microbial 
genome analysis is a solved problem, application of multiple assembly-to-annotation 
pipelines to the same data demonstrates that analysis outcomes are heavily dependent 
on pipeline choice. These choices carry forward into comparative content analysis and 
functional analysis of genomes, and have the potential to significantly impact 
scientific conclusions.  
It is now typical to report on novel microbial genomes in terse genome 
announcements, abstract-style papers that give little information about 
parameterization and execution of bioinformatics processes. A survey of these typical 
papers shows that a wide variety of genome analysis pipelines using combinations of 
bioinformatics tools, from simple to sophisticated, will pass peer review. However, on 
closer examination typical pipelines do not produce identical or even similar results. 
And while in the hands of trained bioinformaticians, the pipelines we tested in this 
paper may be fine-tuned to produce somewhat more accurate results, the literature 
surveyed suggests that this is not what is happening “on the ground” in analysis of 
bacterial genomes. If the protocols outlined in recent genome reports are accurate, in 
many cases these protocols are no more complex than the simple one assembler, one 
gene-finder workflows we have analyzed here. 
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While in many cases, ground truth for novel genome assemblies and 
annotations is not available, we recommend that creators of microbial genome datasets 
consider the following strategies to ensure high quality, reproducible analysis. First, if 
possible, benchmark proposed analysis pipelines using simulated data derived from a 
high-quality genome sequence that is as closely related to the novel sequences as 
possible. Second, maintain an awareness of the variability of assembly-to-annotation 
results. Perform parallel analyses and assess downstream results for pipeline 
dependence. Finally, maintain a detailed record of the analytic provenance of the 
secondary data generated from your raw sequence reads, including pipeline steps and 
parameters. 
2.6  Summary 
 Inconsistencies in genomic analysis can arise depending on the choices that are 
made during the assembly and annotation stages.  These inconsistencies can have a 
significant impact on the interpretation of an individual genome’s content.  The impact 
is multiplied when comparison of content and function among multiple genomes is the 
goal.  Tracking the analysis history of the data – its analytic provenance – is critical 
for reproducible analysis of genome data. 
 The work described in this chapter makes clear the importance of keeping 
consistent annotation methods when constructing draft genomes.  In chapter 3, the 
benchmarking and analysis optimization techniques described here are applied to a 
population sized sequencing dataset of 25 newly sequenced Vibrio vulnificus strains.  
This dataset contains representatives of each of the three known biotypes of V. 
vulnificus.  An in-depth comparative genomics analysis of this magnitude can begin to 
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investigate the genomic difference of the V. vulnificus biotypes and see if they support 
the literature in the known composite differences between them or perhaps begin to 
facilitate discussion within the Vibrio vulnificus community if potential re-
classification of the biotypes and potentially the genotypes is necessary to coincide 
this new differential genomic data with traditional molecular diagnostic techniques. 
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FIGURE 2.1: Crosstab map of frequency levels of assembler and annotation method applied 
to Illumina data.Summary of the major elements of current genomic workflows based on a 
census of 2013 bacterial genome announcements in recent issues of the journal GenomeA and 
Journal of Bacteriology.  Frequency represents the number of times that particular 
combination of sequencer, assembler, and annotation was encountered in survey of 40 papers. 
  
55 
 
 
 
 
       
 
 
 
 
 
FIGURE 2.2: Workflow framework of assembler and annotation methods. 
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FIGURE 2.3: Comparison count of highly conserved contigs for all V. vulnificus  
strains included in this study. 
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FIGURE 2.4: Vibrio vulnificus CECT4606 gene overlap counts.Figure shows the number 
of gene overlaps between all possible assembly-to annotation permutations for 
 V. vulnificus CECT4606. Gene overlaps are defined as two genes that have the  
same start and stop signals and strand orientation on the same contig sequence. 
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FIGURE 2.5: Vibrio vulnificus CECT4606 and CMCP6 gene overlap counts.Each segment in 
the Venn diagram represents the intersection of the number of genes that were identified in 
any   combination of 2 gene prediction methods.  GL  GM = the number of genes that were 
identified in Glimmer and GeneMark.  RS  GM = the number of genes that were identified 
in RAST and GeneMark.  GL  RS = the number of genes that were identified in Glimmer 
and RAST.   The Velvet assembly was used for this comparison. 
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FIGURE 2.6: Genome content comparison for Vibrio vulnificus CMCP6 and CECT5198. 
The Venn diagrams represent the differences in differential gene counts identified when using 
the Velvet and SoapDenovo (Soap) assembly, each with the Glimmer and GeneMark 
annotation.  V. vulnificus CMCP6 is classified as a C-genotype and V. vulnificus CECT5198 is 
classified as an E-genotype. 
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TABLE 2.6: Summarizes the differential GO enrichment terms for the  
workflow descriptions listed in Table 5. If there were more than 20 genes that were 
above the significant p-value cut-off of .005, only the top 20 genes were shown for 
each differential category. 
 
 
Category  GO Identifier GO Name P-value  
Velvet - GeneMark Not Glimmer GO:0005198  structural molecule activity 5.72E-29 
Velvet - GeneMark Not Glimmer GO:0043226  organelle 1.42E-26 
Velvet - GeneMark Not Glimmer GO:0030529  ribonucleoprotein complex 1.33E-23 
Velvet - GeneMark Not Glimmer GO:0003676  nucleic acid binding 2.79E-22 
Velvet - GeneMark Not Glimmer GO:0032991  macromolecular complex 1.83E-20 
Velvet - GeneMark Not Glimmer GO:0043229  intracellular organelle 1.77E-17 
Velvet - GeneMark Not Glimmer GO:0043170  macromolecule metabolic process 3.12E-17 
Velvet - GeneMark Not Glimmer GO:0044260  cellular macromolecule metabolic process 1.88E-16 
Velvet - GeneMark Not Glimmer GO:0044267  cellular protein metabolic process 5.32E-16 
Velvet - GeneMark Not Glimmer GO:0044444  cytoplasmic part 9.10E-16 
Velvet - GeneMark Not Glimmer GO:0006412  translation 1.93E-15 
Velvet - GeneMark Not Glimmer GO:0016410  N-acyltransferase activity 9.63E-15 
Velvet - GeneMark Not Glimmer GO:0019538  protein metabolic process 7.22E-14 
Velvet - GeneMark Not Glimmer GO:0005623  cell 7.45E-13 
Velvet - GeneMark Not Glimmer GO:0044464  cell part 7.45E-13 
Velvet - GeneMark Not Glimmer GO:0005840  ribosome 3.76E-12 
Velvet - GeneMark Not Glimmer GO:0006950  response to stress 5.99E-12 
Velvet - GeneMark Not Glimmer GO:0019843  rRNA binding 1.03E-11 
Velvet - GeneMark Not Glimmer GO:0016407  acetyltransferase activity 2.98E-11 
Velvet - GeneMark Not Glimmer GO:0048519  negative regulation of biological process 8.64E-09 
Velvet - Glimmer Not GeneMark GO:0019692  deoxyribose phosphate metabolic process 0.006635071 
Velvet - Glimmer Not GeneMark GO:0046386  deoxyribose phosphate catabolic process 0.00729927 
Soap - RAST Not GeneMark GO:0005198  structural molecule activity 2.58E-06 
Soap - RAST Not GeneMark GO:0032991  macromolecular complex 1.22E-05 
Soap - RAST Not GeneMark GO:0044267  cellular protein metabolic process 1.77E-05 
Soap - RAST Not GeneMark GO:0019538  protein metabolic process 5.65E-05 
Soap - RAST Not GeneMark GO:0030529  ribonucleoprotein complex 6.35E-05 
Soap - RAST Not GeneMark GO:0043226  organelle 1.01E-04 
Soap - RAST Not GeneMark GO:0006412  translation 1.35E-04 
Soap - RAST Not GeneMark GO:0044444  cytoplasmic part 3.70E-04 
Soap - RAST Not GeneMark GO:0043229  intracellular organelle 0.001603198 
Soap - GeneMark Not RAST GO:0004803  transposase activity 1.21E-07 
Soap - GeneMark Not RAST GO:0032196  transposition 5.88E-07 
Soap - GeneMark Not RAST GO:0003676  nucleic acid binding 4.62E-06 
Soap - GeneMark Not RAST GO:0032991  macromolecular complex 7.65E-05 
Soap - GeneMark Not RAST GO:0005198  structural molecule activity 9.91E-04 
Soap - GeneMark Not RAST GO:0006313  transposition, DNA-mediated 0.001075903 
Soap - GeneMark Not RAST GO:0006259  DNA metabolic process 0.001745285 
Soap - GeneMark Not RAST GO:0009987  cellular process 0.002874757 
Soap - GeneMark Not RAST GO:0019213  deacetylase activity 0.003067666 
Soap - GeneMark Not RAST GO:0051704  multi-organism process 0.004927739 
ABySS - RAST Not Glimmer GO:0005198  structural molecule activity 2.62E-27 
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ABySS - RAST Not Glimmer GO:0030529  ribonucleoprotein complex 5.00E-26 
ABySS - RAST Not Glimmer GO:0043226  organelle 8.03E-26 
ABySS - RAST Not Glimmer GO:0032991  macromolecular complex 1.67E-18 
ABySS - RAST Not Glimmer GO:0003676  nucleic acid binding 3.97E-17 
ABySS - RAST Not Glimmer GO:0043170  macromolecule metabolic process 5.26E-17 
ABySS - RAST Not Glimmer GO:0044444  cytoplasmic part 1.38E-16 
ABySS - RAST Not Glimmer GO:0044267  cellular protein metabolic process 1.48E-16 
ABySS - RAST Not Glimmer GO:0044260  cellular macromolecule metabolic process 1.01E-15 
ABySS - RAST Not Glimmer GO:0005840  ribosome 1.10E-14 
ABySS - RAST Not Glimmer GO:0006412  translation 1.25E-14 
ABySS - RAST Not Glimmer GO:0016410  N-acyltransferase activity 2.80E-14 
ABySS - RAST Not Glimmer GO:0019538  protein metabolic process 5.71E-13 
ABySS - RAST Not Glimmer GO:0005623  cell 1.62E-12 
ABySS - RAST Not Glimmer GO:0044464  cell part 1.62E-12 
ABySS - RAST Not Glimmer GO:0019843  rRNA binding 2.57E-12 
ABySS - RAST Not Glimmer GO:0006950  response to stress 5.03E-12 
ABySS - RAST Not Glimmer GO:0016407  acetyltransferase activity 1.22E-11 
ABySS - RAST Not Glimmer GO:0003735  structural constituent of ribosome 1.98E-09 
ABySS - Glimmer Not RAST GO:0019692  deoxyribose phosphate metabolic process 5.80E-05 
ABySS - Glimmer Not RAST GO:0046386  deoxyribose phosphate catabolic process 1.40E-04 
ABySS - Glimmer Not RAST GO:0009262  deoxyribonucleotide metabolic process 2.65E-04 
ABySS - Glimmer Not RAST GO:0009264  deoxyribonucleotide catabolic process 7.12E-04 
ABySS - Glimmer Not RAST GO:0005515  protein binding 0.002764846 
 
TABLE 2.6: (Continued). 
CHAPTER 3: COMPARATIVE GENOMIC ANALYSIS OF  
VIBRIO VULNIFICUS BIOTYPES 1, 2 AND 3 
 
 
3.1 Introduction 
The species Vibrio vulnificus comprises three known biotypes each of which is 
capable of causing life-threatening infections in humans and in aquatic species. 
Biotype 1 is commonly associated with human infection, primarily through the 
consumption of raw or undercooked mollusks containing V. vulnificus, or by entry 
through an open wound[3]. In Chapter 1, we examined the differences between 
clinical (C) and environmental (E) genotypes of Biotype 1. Biotype 2 is a 
pathogen of eels and other marine species, and rarely causes human infection[3].  
To date, biotype 3 has only been observed as the causative agent in an outbreak 
among fish market workers in Israel[72].  The V. vulnificus biotypes are currently 
distinguished based on their biochemical, serological, and molecular 
characteristics [73-75].  While these characteristics can give some insight into 
phenotypic variation between the biotypes, they do not provide detailed 
information about the genetic and functional differences.  To date, there has not 
been an in-depth comparative genomics study incorporating sequences from all 
three biotypes of Vibrio vulnificus.  Identifying differences in genomic content 
among the biotypes will lead to greater insight into their mechanisms of 
pathogenesis and survival in the environment.   
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In this chapter, we describe the sequencing, assembly, and comparative 
analysis of 10 V. vulnificus strains, with the intent of establishing the core virulence 
and survival mechanisms shared between the biotypes, as well as identifying the 
virulence and survival mechanisms that are specific to each biotype. These strains are 
representative of a larger data set that includes 25 biotypes, including additional 
Biotype 1 and Biotype 2 strains. The analysis approach, and results, described here 
preview key elements of the approach and findings from the comprehensive study of 
25 strains. 
3.2 Background 
In previous comparative studies of V. vulnificus, biochemical markers along with 
sequences of selected genomic regions have commonly been used to distinguish 
between the biotypes. There are 13 biochemical characteristics used to differentiate 
between the biotypes.  Of these tests, the indole production reaction is commonly 
reported in the identification of V. vulnificus biotypes in bench-work settings. The 
indole test is a biochemical test performed on bacterial species to determine the ability 
of the organism to convert tryptophan into indole. It is commonly reported that 
Biotype 1 isolates have positive indole reactions, while Biotype 2 have negative 
reactions [74-76]. The Biotype 3 indole test is positive, but in conjunction with other 
biochemical properties it can generally distinguish Biotype 3 from the other two 
biotypes [73]. However, the classification of the biotypes by these methods is not 
entirely clear cut. Biosca et al. [77] reported on a V. vulnificus isolate that is classified 
as Biotype 2 and virulent to eels, but has a positive indole reaction.  This suggests a 
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diversity of biochemistry that may not be correctly represented by the small biomarker 
set currently used for V. vulnificus classification. 
When DNA sequence is used as a marker for biotype in V. vulnificus, Biotype 1 
isolates are associated with the presence of the genomic XII region. This region was 
identified by Cohen et al. [39], and some genes within this region are suggested to 
play a role in Biotype 1 pathogenicity.  In comparison, the majority of Biotype 2 
isolates contain at least two plasmids, a virulence plasmid and a putative conjugative 
plasmid[78].  To date, this extra-chromosomal content has not been reported in any 
Biotype 1 isolates and its presence can be used as a diagnostic for Biotype 2.  
Until recently, only the molecular characteristics of the Biotypes could be probed, 
and only Biotype 1 genomes had been completely sequenced. In 2010, short read data 
was made available for a single Biotype 2 genome, ATCC 33149[10] and in 2013, the 
sequencing of one Biotype 3 environmental genome Vibrio vulnificus VVyb1, was 
reported[79].  The Danin-Poleg et al. [79] study identified 217 unique protein-coding 
sequences that were not in any of the known V. vulnificus genomes.  The earlier study 
that produced Biotype 2 data employed the ABI SoLID next generation sequencing 
platform, which produces very short read fragments, thus making it impossible to 
assemble ab initio.   Since the Biotype 2 genome in that study was assembled with a 
Biotype 1 genome as its reference, it was not possible to identify Biotype 2 specific 
regions.  In the more recent Danin- Poleg et al. [79] study, the Biotype 3 genome was 
sequenced using the Illumina next generation sequencing platform.  The draft genome 
assembly comprises 140 contigs. While the Illumina sequencing platform produces 
sufficient read lengths to assemble the reads ab initio and identify Biotype 3 specific 
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regions there still remains a level of uncertainty around genome content, due to its lack 
of closure.  As we observed in Ch. 2, sequenced data for bacterial genomes obtained 
using the Illumina platform with a single insert size fails to completely capture gene 
content, potentially missing about 1% of genes even when paired reads in excess of 
100x coverage are produced.  However, it is likely that the identification of over 200 
Biotype 3-unique genes in the strain examined in that study is reasonably accurate. 
By sequencing and comparing a wider variety of Biotype 1, 2, and 3 strains that 
are differ in their isolation method and genotype can we begin to understand more 
about the differences between the Biotypes than has previously been possible. Using 
methods similar to those described in Chapter 1 we will be able to observe the 
differences in gene content in strain to strain comparisons within the same biotype, 
biotype to biotype comparisons, and isolation to isolation comparisons.  This study 
will provide us with a better understanding of the virulence and survival mechanisms 
that are shared between the biotypes as well as those that are biotype-specific.  
Comparison of large number of strains may also call into question the relevance of the 
current biotype designations.  The key to understanding these classifications will be 
observing differences between the core genomes of the biotypes.  If we observe 
consistent and specific genome content for each biotype, regardless of strain-to-strain 
differences within biotype, then it is more likely that the traditional biotype 
designations are representing the underlying evolutionary history of V. vulnificus. 
3.3   Materials and Methods 
3.3.1 Growth Conditions and DNA Isolation 
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 V. vulnificus strains were grown in the laboratory of Dr. Craig Baker-Austin at 
the Center for Environment, Fisheries, and Aquatic Science in Weymouth, UK. Cells 
were grown at 28°C for 24 hours in tryptone soy broth or on solid agar media, 
supplemented with 5 g/liter NaCl.  Strains were cryogenically stored at -80°C prior to 
use, supplemented with 20% (vol/vol) glycerol.  Late-logarithmically grown bacterial 
suspensions were pelleted and DNA extracted using a Mini-prep protocol.  The quality 
and quantity of DNA was subsequently ascertained spectrophotometrically using 
NanoDrop ND1000 (NanoDrop Technologies, Wilmington, DE).  Extracted DNA was 
run on 2% agarose gels to further check the quality and quantity of extracted DNA.  
Table 3.1 summarizes the provenance information for each of the 25 newly sequenced 
V. vulnificus strains discussed in this chapter, as well as the V.vulnificus reference 
genomes. 
3.3.2 Genome Sequencing and Assembly 
V. vulnificus strains were sequenced at The Genome Analysis Centre (TGAC, 
Norwich, UK) using the Illumina HiSeq2000 platform.  Sequencing was carried out on 
libraries in pools of 12 strains in one lane of an Illumina plate. Sequence reads are 100 
bp (PE) reads. All analysis subsequent to sequencing was then performed at UNC 
Charlotte.  
FastQC was used to evaluate the quality of the sequence reads for each 
library[62]. We removed sequenced reads that contained any ‘N’ calls as a data-
cleansing step.  If a sequence read contained 1 or more ‘N’, both the read and its pair 
would be removed.  After the data-cleansing step we sampled a subset of reads that 
was equivalent to 100x coverage based on the Lander and Waterman statistic[63]; for 
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a few data sets, lower coverage was used due to the amount of sequence remaining 
after ‘N’ removal. Vibrio vulnificus ORL 1506 did not go through the random read 
sampling protocol see Appendix B.  
We used Velvet version 1.0.12 [49] and VelvetOptimiser version 2.2.0 to 
assemble reads into contigs.  This decision was guided by the simulation results 
obtained in Chapter 2. The VelvetOptimiser parameters were used to initiate the 
Velvet assembler.  The VelvetOptimiser hash value ranged from 73 to 93.  The read 
description parameter was set to “-shortPaired”.  Table 3.2 summarizes the sequence 
assembly statistics for each of the newly sequenced V. vulnificus strains included in 
this study. 
3.3.3 Genome and Gene Characterization 
Feature identification for each strain was performed on the contig set for each 
isolate using an in-house pipeline of published microbial annotation tools constructed 
using the Taverna workflow management system[64] .  The feature identification 
methods that were used were Glimmer3.02[13] (Glimmer) and GeneMark.hmm[14] 
(GeneMark).  Both packages are widely used ab initio gene finding applications 
recognized and accepted by NCBI, and both are publicly available.  Glimmer was used 
with default parameters.  An exception was that the circular chromosomes were 
treated as linear in the analysis.  This setting was used to prevent each contig from 
being treated as an individual circular chromosome. Both Glimmer and 
GeneMark.hmm were trained using sequence from known Vibrio genomes. The 
training sets chosen for each method are not identical, and training set choices were 
constrained by the capabilities and needs of the software. The Glimmer training set 
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was constructed with all completely sequenced Vibrio spp. genomes available as of 
June 2013. Table 3.3 contains a list of all the completely sequenced genomes used as 
training data in this study.  GeneMark was used with its default parameters, and the 
model was trained on chromosome 1 of the V. vulnificus CMCP6 genome.  To ensure 
that we could compare these newly sequenced genomes to the previous ones 
constructed in Chapter 1, and to the completely closed Vibrio vulnificus Biotype 1 
genomes we followed the same annotation merging procedure described in Chapter 1.  
After the gene sequences were identified, we used Blast2Go to annotate the gene 
sequences [80].  Blast2Go performs a BlastP protocol against the non-redundant 
database at NCBI.  Based on the results of the BlastP search, Gene Ontology (GO) 
terms are associated to each gene were associated on the results.  The detailed 
description of the Blast2Go annotation methodology is in Conesa et al. [80]. 
3.3.4   Gene Clustering 
OrthoMCL version 2.0[15] was used to cluster the genes predicted in the 
newly sequenced genomes with genes from other completely characterized Vibrio spp. 
The purpose of the ortholog clustering procedure is to establish relationships among 
genes from genome to genome. For the purpose of content comparison, a cluster of 
genes that contains one ortholog from each genome in a study is considered to 
represent the same gene when content is being compared. The implied relationship 
between the genes is that they have an evolutionary common ancestor. OrthoMCL has 
been shown to outperform other stand-alone methods for ortholog clustering [15].  
OrthoMCL uses an all-against-all BlastP comparison of sequences as an input step, 
followed by application of a Markov clustering procedure.  The e-value cutoff for the 
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BlastP algorithm was 1e-5.  Default parameters were used for OrthoMCL, except that 
clusters were formed based on a shared sequence similarity of 70%.  Details for the 
parameter cut-off are explained in 1.2.4.   
3.3.5 Gene Content Comparison 
The OrthoMCL [15]clustering generated during the annotation step was used 
as the basis for identification of differentiating genes.  Identified gene features and 
OrthoMCL results were stored in a locally developed OLAP data warehouse 
(GenoSets) that supports queries across aggregate data generated by a variety of 
genomic annotation and comparison methods as described in Cain et al.[28].   
Annotations for the novel genomes reported were generated as described in section 
1.3.4.  Feature boundaries were determined from the annotation and stored in a 
GenoSets database. The software facilitates gene presence-absence queries to be 
formulated in GenoSets at different levels, and was used to investigate differences 
among Biotype groups as well as individual strains. 
In order to provide a standard means of comparison for feature attributes we 
established relationships between features using two methods.  First, we estimated 
orthologous relationships between genes using OrthoMCL as described in the previous 
section.  For functional analysis, gene features identified in the newly sequenced V. 
vulnificus strains used the GO terms assigned by Blast2Go.  For functional 
comparison purposes, we used a controlled vocabulary to identify genes and other 
features.  The Gene Ontology (GO) [19,20] provides standardized terms for the 
description of gene products in terms of biological processes, cellular location, and 
molecular function. 
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3.3.6 Phylogenetic Analysis  
There were 2651 single-copy ortholog clusters identified within the 25 newly 
sequenced V. vulnificus strains. Ortholog clusters were constructed based on the 
criteria defined in section 3.3.4. Table 3.1 contains a list of the 25 newly sequenced V. 
vulnificus strains included in the phylogenetic analysis.  The strains included in this 
analysis represent all the known biotypes and subtypes found within V. vulnificus.  We 
performed a phylogenetic analysis following the methods used in [81, 82, and 2].  We 
randomly selected protein sequences of approximately 10% of the single-copy 
ortholog clusters identified (266 genes) and used the sample as a basis for construction 
of a maximum likelihood tree, following the approach used in Hasan et al 2010.  
MUSCLE version 3.8.31 was used to align sequence members of each ortholog cluster 
independently [83].  Individual alignments were used to minimize rearrangements 
within the multiple sequence alignment [2].  Once each individual protein alignment 
was built, the independent alignments were concatenated.  phyML 3.0, a maximum 
likelihood method, was used to generate a phylogenetic species tree with 100 
replicates for bootstrapping [84].  The tree was visualized with Figtree [85].  Three 
independent samplings were tested and all three produced trees with highly similar 
topologies. 
3.4 Results and Discussion 
3.4.1 Genome Sequencing and Assembly Statistics 
 An average of 785,799,011 paired end sequencing reads were generated for the 
newly sequenced V. vulnificus strains included in this chapter.  Table 3.2 details the 
number of paired end reads generated for each of the strains.  The read length was 100 
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bp.  The number of contigs constructed ranged from 78 to 4658. The average N50 
value was 19156.32. The raw genome data for each of the newly sequenced genomes 
were randomly sampled to 100x genome coverage, with the exception of those 
genomes that did not have enough sequence reads after the removal of ‘N’ characters 
in the sequence and V. vulnificus CDC 9030-95 (ORL 1506), see Appendix B.  Magoc 
et al. [55] reported that 100x is sufficient genome coverage to construct a microbial 
genome from paired end Illumina sequence reads. In Chapter 2, we tested multiple 
assembly methods on read sets at different coverage depth and found that using 
additional reads beyond 100x coverage did not appreciably improve assemblies, while 
adding significantly to the computational time required to assemble the genomes. 
3.4.2 General Properties of the Biotype 1, 2 and 3 Genomes 
 All of the Biotype 1, 2 and 3 genomes are composed of 2 circular 
chromosomes containing an estimated total of approximately 5.6 MB – 5.8 MB of 
genomic DNA.  The Biotypes however do differ in the extra-chromosomal DNA.  Of 
the newly sequenced Biotype 1 genomes only 1 has plasmid DNA present, Vibrio 
vulnificus CECT 4606.  All of the newly sequenced Biotype 2 and 3 genomes have 1 
or 2 plasmids.  Table 3.1 summarizes the predicted gene content of each sequenced 
draft genomes. 
3.4.3 Gene Content that Characterizes V. vulnificus Biotypes 
We identified approximately 3690 common genes between the V. vulnificus 
biotypes.  The differential gene counts are based on using by V. vulnificus strains 
CMCP6 (BT1), CECT4606 (BT2), 11028 (BT3), and 2(BT3) to represent biotypes 1, 
2 and 3, respectively. V. vulnificus CMCP6 was used to represent the Biotype 1 
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genomes due to its recent re-annotation [23].  We identified 384 genes that are in V. 
vulnificus CMCP6 isolates that are not in any of the Biotype 2 or Biotype 3 isolates.  
There are 628 genes in the representative Biotype 2 isolate that are not present in any 
of the Biotype 1 or Biotype 3 isolates. Biotype 3 has 420 genes that are present in both 
representative Biotype 3 isolates, but not present in the Biotype 1or Biotype 2 
genomes.  Figure 3.1 summarizes the gene count differentials among the biotypes. 
There are many possible queries that can be constructed within this data set, each of 
which will produce a lengthy list of differentiating genes. Here, we focus on several of 
the most significant comparisons. 3.4.4 General characteristics of Biotype 1 strains 
isolated from clinical sources  
All of the known V. vulnificus biotypes have members that have been isolated 
from human infections (clinical isolates). This distinction is independent of the “C-
type” and “E-type” classifications discussed in Chapter 1; Biotype 2 and 3 clinical 
isolates identified thus far are nonetheless characterized as E genotypes by molecular 
methods. In this differential analysis, we examine the differences among clinical 
isolate strains of each of the three biotypes. The result set represents those genes, 
which are common among those strains that cause human infection, and identifies 
different functional capabilities in clinically significant strains of each of the three 
biotypes. Here, we discuss several typical examples of genes that only appear in the 
Biotype 1 clinical strains. V. vulnificus strains CMCP6, MO6-24/O, YJ016, ATL-
9824, NSV 5830, ORL 1506, and C718AV represented the biotype 1 strains, V. 
vulnificus strains 11028 and 12 represented the biotype 3 strains, and V. vulnificus 
strains CIP8190, CECT4866, and 94-8-112 represented biotype 2 strains.  The results 
78 
 
in Table 3.4 represent the differences in gene content between V. vulnificus CMCP6, 
YJ016, and MO6-24/O. These strains are completely characterized and their 
functional annotations were transferred to the annotations of the newly sequenced 
biotype 1 clinically isolated strains.  Of the genes that were identified as only 
appearing in biotype 1 strains relative to clinical isolates of biotypes 2 and 3, we 
confirm six functional systems that were also identified as characteristic of Biotype 1 
clinical isolates in our previous differential analysis, Morrison et al.[2]. 
3.4.4 General Characteristics of Biotype 1 Strains Isolated From Clinical Sources 
In Table 3.4, we highlight Biotype 1 genes from clinically isolated C-type strains.  
The mannitol-1-phosphate 5-dehydrogenase and mannitol operon repressor genes 
were identified in our previous study[25] as a common feature of clinical Biotype 1 
strains, and they are suggested as being associated with clinical genotype 
virulence[25].  We also previously identified Biotype 1 clinical isolates possessing 
unique GGDEF family proteins (GGDEF family protein YeaJ) located in an operon 
with a putative two-component response regulator and a fimbrial protein Z 
transcriptional regulator. These genes are unique to the Biotype 1 clinical strains 
relative to the other two Biotypes as well [2].  
In addition to the previously identified mannitol-associated genes and the 
fimbrial protein Z operon [2], we find other groups of genes, which characterize 
Biotype 1 relative to Biotypes 2 and 3.  One such group is methyl-accepting 
chemotaxis proteins. Chemotaxis is the process by which the movement of cells is 
directed by chemicals in the environment.  Since V. vulnificus is commonly found in 
estuarine environments, the assumption would be that all V. vulnificus have some sort 
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of drive to direct movement toward nutrient rich environments. The additional 
chemotaxis genes characterizing Biotype 1 may result in increased responsiveness to 
environmental stimuli relative to the other two biotypes. Biotype 1 strains are the most 
frequently reported sources of human infection. Experiments targeting these genes 
would need to conducted, to determine whether enhanced chemotactic capabilities are 
perhaps a phenotypic advantage for Biotype 1 clinical isolates, or play a role in their 
recognition of human tissue as a nutrient rich environment.  
Another set of genes, which seem to be present in Biotype 1 and absent in other 
biotypes is a portion of an arsenic resistance operon. Arsenic is a contaminant of water 
supplies around the world and one of the most toxic inorganic ions [86]. It is likely 
that V. vulnificus encounters this toxin in some environments and that arsenic 
resistance may provide a survival advantage for some strains. It has been reported in 
the literature that arsenic levels increase in fresh and marine water when crude oil is 
present [87].  The oil interrupts the natural filtration process of sediments bonding 
with arsenic, which results in increased levels of arsenic in the body of water [87,88].  
Tao et al. [89] reported on the prevalence of Vibrio vulnificus cells surviving in tar 
balls collected as a result of the 2010 BP Deepwater Horizon oil spill.  Their results 
showed total aerobic bacterial counts were (> 10
6 
CFU/g) in tar balls collected from 
Alabama and Mississippi (USA)[89].  While they did report that V. vulnificus did not 
grow when exposed to tar-ball enriched seawater agar [89], it is plausible that this 
operon is contributing to the survival of V. vulnificus within the tar balls. Again, 
experiments targeting the arsenic resistance operon would need to be conducted to 
clarify the role of arsenic-resistance in survival mechanisms of V. vulnificus 
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3.4.5 Biotype Differentials Among E-genotype Strains 
 Vibrio vulnificus JY1305 is traditionally classified as a biotype 1 strain, 
isolated from an environmental source and therefore designated as an E-genotype 
(B1E). As stated in the previous section, all Biotype 2 and 3 strains are classified as E-
genotypes, regardless of their source of isolation. Our goal in this comparison was to 
contrast E-genotype strains from each Biotype classification. The genes identified in 
this comparison represent a common core of E-genotype genes across the biotypes, 
and the differential genes should be characteristic of biotype. Strain JY1305 was used 
to represent biotype 1, E-genotype strains in a comparative genome query.  The strains 
included in this comparison are V. vulnificus JY1305, representing biotype 1 E-type 
strains, V. vulnificus CECT4606 for biotype 2 E-type strains, and V. vulnificus 11028 
for biotype 3 E-type strains.   
Of the 328 specific genes identified as specific to Biotype 1 in this analysis, we 
highlight a gene associated with iron utilization. Iron utilization is especially of 
interest in the context of Vibrio vulnificus pathobiology, since this pathogen is 
dangerous to hosts in a condition of iron overload [68, 69].  Several studies have 
reported on the correlation between V. vulnificus infections and increased levels of 
iron in animal models and infected individuals [3, 68, and 69].  However there have 
been no clinical cases of infection by JY1305.  Differences in expression of iron 
utilization genes were observed in an RNA-Seq study of Biotype 1 C and E strains, in 
which expression under human serum and artificial seawater conditions was compared 
(E. Blackman and T. Williams, personal communication). Differences in iron 
utilization might also potentially support the prevalence of biotype 1 strains in human 
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infection over biotype 2 and 3[4]. Iron utilization gene differentials were not identified 
in the comparison of the clinical isolates described in the previous section and 
demonstrates the power of changing the data aggregation strategy when carrying out 
comparisons of a large number of bacterial strains of varied origin and type. 
Vibrio vulnificus CECT4606 is traditionally classified as a biotype 2 strain, 
isolated from an environmental source and therefore designated as an E-genotype 
(B2E).  This strain was used to represent biotype 2, E-genotype strains in the 
comparison among E-genotypes of different biotype. Of the 648 B2E specific genes 
identified, several were characterized as being associated with bacterial pathogenesis.  
Table 3.5 lists a selection of potentially significant differential genes for V.vulnificus 
CECT4606. There is no evidence that supports the ability of V. vulnificus CECT4606 
to cause infection within either human or animal hosts. Nevertheless, several secretion 
proteins of the type II (T2SS), type IV (T4SS), and type VI (T6SS) secretion systems 
were identified.  These systems (T4SS) have traditional been associated with V. 
vulnificus Biotype 1 strains (CMCP6 and YJ016) [2], which are known to cause 
infections within humans. If their presence is shown to be consistent across the 
remaining Biotype 2 strains, it could provide an explanation of the occasional isolation 
of Biotype 2, E-genotype strains from clinical samples. The presence or absence of 
secretion system genes alone does not fully explain the capability of the strain to act as 
a pathogen, however. There is evidence that not all Biotype 1 strain C-type strains 
(MO6-24/O) that are capable of causing infection indeed have all components of the 
T4SS system [2]. Uptake of pathogen-associated genes of this type is thought to be the 
result of horizontal gene transfer.  
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Another biotype 2 specific gene suggests horizontal gene transfer activity is the 
zonula occludens toxin (ZOT).  ZOT has been documented in Vibrio cholerae 
infections as being associated with the symptom of diarrhea [90].  In 1970, in a 
clinical case of V. vulnificus, it was reported that the patient had symptoms of diarrhea, 
vomiting, and hemorrhagic rash; all of which are common symptoms of V. cholerae 
infections [91-93]. These symptoms suggest the presence of the cholera-associated 
ZOT, although molecular confirmation of the presence of ZOT in similar cases of 
infection would be necessary to support that hypothesis.  
A third interesting finding was that several of the mannitol-associated genes 
identified in Chapter 1 as characteristic of C-type strains were identified as gene 
differentials for this B2E strain. That the two groups share this common functionality 
may suggest a closer or more ambiguous relationship between the Biotype 2 strains 
and Biotype 1 C-genotype strains than previously suspected. The presence of 
mannitol-associated genes in the C-genotype strains is commonly associated with 
virulence capabilities [25] and sees section 1.4.2. In the Oliver laboratory, 40% of the 
E-type strains tested have been found to contain the mannitol operon and are able to 
ferment this sugar [37, 38]. CECT4606 is one of those E-type strains included in this 
category. 
 While further comparative analysis will be necessary to sort out the complex 
relationships within and between the groups, these findings suggest that a single gene 
or even a group cannot be used to differentiate between the biotypes with certainty and 
that a more detailed classification system may be needed.  
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Vibrio vulnificus 11028 is classified as a biotype 3 strain, isolated from a 
clinical source with an E-genotype classification (B3E).  This strain was used to 
represent biotype 3, E-genotype strains in the comparative analysis of E-genotypes. V. 
vulnificus 11028 was isolated from a human sample though classified as an E-
genotype strain using molecular criteria.  In chapter 1 it was established that E-type 
strains rarely cause human infections. The genes characteristic of this infectious 
Biotype 3 strain may therefore give some insight into the varying means by which V. 
vulnificus genomes acquire the ability to act as human pathogens.  
Of the 476 B3E specific genes identified, genes associated with toxins RelE 
and RelB are highlighted.  The relBE operon inhibits translation during nutritional 
stresses [94-96.  In the Yamamoto et al. (2002) study [97], they presented a case when 
the Escherichia coli relE gene was expressed inducibly in a human osteosarcoma cell 
line and it caused growth inhibition and cell death by apoptosis.  The functional 
implications of its presence in V. vulnificus remain unclear. It may play a role in this 
organism’s ability to cause symptoms related to cell death in the infected host, causing 
conditions such as blistering dermatitis.  It also possible that relE may play a role in 
BE3 cell deaths in nutrient limiting environments, which may possibly explain the 
limited number of cases of biotype 3 infection reported.  Further investigation of the 
role of RelE and RelB in the biotype 3s will need to be done in order to elucidate their 
role.  These toxin genes may serve as a differential characteristic of V. vulnificus 
biotype 3 strains from either a clinical or environmental source, and may be used in 
combination with other genes as a diagnostic marker for biotype 3 strains. 
3.4.6 Phylogeny of  V. vulnificus Biotypes and Genotypes 
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 Figure 3.2 is a phylogeny of the Vibrio vulnificus strains listed in Table 3.1.  
The phylogeny includes all of the 25 recently sequenced strains of V. vulnificus along 
with previously sequenced strains.  The overall consensus of the three trees is similar 
to the evolutionary relationships previously observed between the biotypes; with the 
biotype 3 strains placed between the biotype 1 and 2 strains [98-102] and also follows 
the pattern of divergence between C and E genotypes seen in Morrison et al. [2].  
However, there are quite a few strains that do not follow previously published V. 
vulnificus biotype phylogenies. As previously noted, over 25% of V. vulnificus strains 
are atypical in their response to one or more molecular assays, which suggests that 
there may be more diversity among strains and biotypes than is adequately represented 
by the traditional molecular assays. The phylogenetic tree presented here is based on a 
significant number of conserved genes. It was constructed using an approach, which 
we have previously used to produce a phylogeny of the genus Vibrio; that phylogeny 
was congruent with accepted ideas of the phylogeny of that genus.  It is likely that the 
phylogeny presented here represents the basic relationships among the strains 
accurately, although addition of an out-group species from within the genus would 
clarify the tree topology.  The two biotype 3 strains are consistently placed between 
biotype 1 and 2 strains within the three sampling trees.  There are three biotype 2 
strains (CECT4606, CECT5769, and 95-8-162) that are closer in evolutionary 
relationship to the other two biotypes than to the remainder of the biotype 2 strains, 
which consistently form a cluster elsewhere in the tree. It is possible that the meta-data 
collected for these strains is incorrect, but it may also be that the division between 
Biotype 1 and Biotype 2 is not as unambiguous as previously thought.  Molecular 
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assays need to be performed on the strains (CECT4606, CECT5769, and 95-8-162) to 
confirm their classification as Biotype 2.  
3.5 Summary  
Ten strains of various Vibrio vulnificus biotypes and genotypes have been 
sequenced, assembled and annotated into draft genomes.  These draft genomes have 
provided the basis of a novel in-depth comparative genomics study of V. vulnificus 
biotypes and biotype-to-genotype combination.   As a result of the differential analysis 
we have identified Biotype 1, 2, and 3 specific genomic regions.  These insights can 
be used to establish an improved classification system for V. vulnificus.  
Approximately 25% percent of V. vulnificus strains are known to have some sort of 
molecular, functional, or biochemical discrepancy from the ‘norm’ associated with 
their currently assigned biological classification. We anticipate that the regions we 
have identified in this comparison may provide insights into the infection and survival 
mechanisms specific to each of the biotypes and genotypes. This work will facilitates 
further molecular investigation of gene and biochemical pathway targets that can be 
used to assess the relationship of genomic differences to function in a bench work 
setting.  
3.6 Conclusion of Work 
Overall, this work demonstrates the benefits of large-scale sequencing to 
develop differential datasets for microbes.  It represents an important scientific step in 
a significant collaborative effort, in which methods and knowledge from multiple 
disciplines are used to solve a complex problem.  The bioinformatics work presented 
here provides a foundation of tools and analysis techniques for future studies in 
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Vibrios and other bacteria. The biological outcome – analysis and comparison of V. 
vulnificus Biotypes – provides a wealth of targets for future investigation by 
collaborators and future students in the Gibas group. 
With the capabilities of NGS technologies, sequencing of complete microbial 
genomes can be accomplished within a matter of days.  It is foreseeable that in-depth 
comparative genomics studies of many closely related strains will soon be standard 
practice for researchers investigating the biology of microbes. The contributions of 
this work are two-fold. First of all, it contributes to specific understanding of the 
biology of Vibrio vulnificus, establishing the differences in gene content that define 
clinical and environmental genotypes of Biotype 1 strains, as shown in Chapter 1 and 
in Morrison et al. 2012.That study was the first to report on several E-type specific 
genomic regions.  An important result was the observation that the SPANC theory 
may potentially be one of the driving forces between the diversification of the 
genotypes in V. vulnificus.   Chapter 3 lays the groundwork for a similar manuscript 
defining the differences in genetic content between Biotypes 1, 2 and 3. Again, many 
of the differential results in this chapter will be novel findings for V. vulnificus, which 
have not been observed previously, or have been observed only in part. Identification 
of these gene differentials provides microbiologists with the molecular tools to 
investigate new aspects of the different survival mechanisms of the biotypes in 
different isolation sources.  Also, these findings may bring the attention of 
microbiologists to focus on genes that previously were deemed insignificant in 
distinguishing characteristics between the biological classifications of V. vulnificus.   
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Secondly, this work contributes to an understanding of bioinformatics best 
practices for microbial genome assembly and annotation. The results in chapter 2 can 
be a point of reference in future sequencing projects, and provide a guide for other 
researchers on the importance of maintaining consistent analysis practices when 
identifying the similarities and differences in NGS datasets. 
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APPENDIX A:  POLYMERASE CHAIN REACTION PRIMERS FOR  
VIBRIO VULNIFICUS DNA CONTENT VALIDATION 
 
 
Primer Name Primer Sequence Identification Purpose 
csr AupF1 
csr AupF2 
5’-CGACCTTATTGCTTCCCGAT 
5’-GTCAGCCTCTATCATTCAGAG 
V. vulnificus Chromosome 
1 
Rpod UP 
Rpod DOWN 
5'-GACCAAGCACGTACGATTC 
5'-GCATTTGCATACGCTCTG 
V. vulnificus Chromosome 
1 
vvhA F 
vvhA R 
5'-AGCGGTGATTTCAACG 
5'-GGCCGTCTTTGTTCACT 
V. vulnificus Chromosome 
2 
pepRF F2  
pepR3  
5'-AGTTGTCCATATGCCTGCCTC 
5'-ACGAGAGTTTCCGCTGATGA 
V. vulnificus Chromosome 
2 
vvSSF1 
vvSSR1 
Seq 5’ GGCAAAGCCTCTTGTAGACAC 
Seq 3’ TGATAGAGTGGCAAGGGTGCC 
Plasmid content 
vvF2 
vvR2 
Seq 5’ ACACACCGCATCAACGGATTGAAC (plus) 
Seq 5’ GCAAGGGTGCATAAAAGGAGTGCC (minus) 
Plasmid content 
Two sets of Primers were generated (the Primer 3 software) using the conserved regions of Plasmid YJ016 and PC4602-1 
 with expected product length of 244 and 209bps. The conserved sequenced used for primer generation were blasted against 
 the genomic sequence of Vibrio vulnificus CMCP6 and YJ016 stains to ensure that they were exclusively for two plasmid 
sequences. 
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APPENDIX B:  VIBRIO VULNIFICUS CDC 9030-95 (ORL 1506) 
 
Inaccurate provenance information of the V. vulnificus CDC 9030-95 (ORL 
1506) genome sequence data caused it to be overlooked during the removal of the ‘N’ 
character step.  Each genome was run independently, human error is at fault. 
